"","GO.cluster","IC","GO.ID","term","definition","Oral_elim.genes_frequency","Oral_elim.pvalue","Oral_elim.-log10_pvalue","Oral_elim.Significant_genes","Oral_elim.Significant_genes_symbol","Aboral_elim.genes_frequency","Aboral_elim.pvalue","Aboral_elim.-log10_pvalue","Aboral_elim.Significant_genes","Aboral_elim.Significant_genes_symbol","Cluster.name"
"1","1",8.86,"GO:0007412","axon target recognition","The process in which an axon recognizes and binds to a set of cells with which it may form stable connections.","55.556% (5/9)",0.0002282419,3.64,"Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g28466.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___TS.g1768.t1","Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Ephrin-B2a;Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","0% (0/9)",1,0,NA,NA,"Cluster 1: neuron projection development"
"2","1",8.57,"GO:0031290","retinal ganglion cell axon guidance","The process in which the migration of an axon growth cone of a retinal ganglion cell (RGC) is directed to its target in the brain in response to a combination of attractive and repulsive cues.","50% (6/12)",0.0001085741,3.96,"Pocillopora_acuta_HIv2___RNAseq.665_t;Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___TS.g1768.t1;Pocillopora_acuta_HIv2___TS.g24662.t1","POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related)","16.667% (2/12)",0.0638277,1.19,NA,NA,"Cluster 1: neuron projection development"
"3","1",5.53,"GO:0007411","axon guidance","The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.","12.048% (20/166)",0.2559344,0.59,NA,NA,"9.639% (16/166)",0.0002237799,3.65,"Pocillopora_acuta_HIv2___RNAseq.g21418.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g942.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b","POU domain protein CF1A (Chorion factor 1A) (CF1-A) (Protein drifter) (Ventral veins lacking protein);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Protein Wnt-8b;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-2;Roundabout homolog 2;Roundabout homolog 2;Roundabout homolog 1;Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-2;Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protein Wnt-8b;Protein Wnt-8b;Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","Cluster 1: neuron projection development"
"4","1",8.86,"GO:0014012","peripheral nervous system axon regeneration","The regrowth of axons outside the central nervous system (outside the brain and spinal cord) following an axonal injury.","11.111% (1/9)",0.5042862,0.3,NA,NA,"33.333% (3/9)",0.003040497,2.52,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","Cluster 1: neuron projection development"
"5","1",6.68,"GO:0050773","regulation of dendrite development","Any process that modulates the frequency, rate or extent of dendrite development.","2.941% (2/68)",0.9679119,0.01,NA,NA,"11.765% (8/68)",0.002437385,2.61,"Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g21418.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g9056.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g25584.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1","Protocadherin Fat 3 (FAT tumor suppressor homolog 3);POU domain protein CF1A (Chorion factor 1A) (CF1-A) (Protein drifter) (Ventral veins lacking protein);Roundabout homolog 1;CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","Cluster 1: neuron projection development"
"6","2",7.45,"GO:0045669","positive regulation of osteoblast differentiation","Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.","5.405% (2/37)",0.7769338,0.11,NA,NA,"18.919% (7/37)",0.0002495652,3.6,"Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g3780.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g23673.t1","Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Fibrillin-2 [Cleaved into: Placensin];Collagen triple helix repeat-containing protein 1;Protein kinase C-binding protein NELL1 (NEL-like protein 1);Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Signal peptide, CUB and EGF-like domain-containing protein 3","Cluster 2: cell differentiation"
"7","2",6.64,"GO:0050768","negative regulation of neurogenesis","Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system.","7.143% (5/70)",0.6108491,0.21,NA,NA,"11.429% (8/70)",0.002930765,2.53,"Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27337.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___TS.g11002.t4","Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Protein Wnt-7a;Transcription factor HES-4 (Hairy and enhancer of split 4) (Protein hairy-2);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Cluster 2: cell differentiation"
"8","2",8.35,"GO:0002052","positive regulation of neuroblast proliferation","Any process that activates or increases the rate of neuroblast proliferation.","13.333% (2/15)",0.3116574,0.51,NA,NA,"26.667% (4/15)",0.001474884,2.83,"Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g5115.t2","Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","Cluster 2: cell differentiation"
"9","2",6.16,"GO:0050769","positive regulation of neurogenesis","Any process that activates or increases the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system.","4.202% (5/119)",0.9498822,0.02,NA,NA,"10.924% (13/119)",0.009785502,2.01,"Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7509.t2;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g5115.t2","Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Roundabout homolog 2;Roundabout homolog 2;Roundabout homolog 1;Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","Cluster 2: cell differentiation"
"10","2",7.8,"GO:0042659","regulation of cell fate specification","Any process that mediates the adoption of a specific fate by a cell.","11.538% (3/26)",0.3089122,0.51,NA,NA,"19.231% (5/26)",0.001819028,2.74,"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g3509.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g5006.t1b","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","Cluster 2: cell differentiation"
"11","2",7.21,"GO:0001709","cell fate determination","The cellular developmental process involved in cell fate commitment that occurs after cell fate specification, in which a cell is irreversibly committed to a cellular developmental fate which is heritable on cell division.","6.452% (2/31)",0.6868999,0.16,NA,NA,"16.129% (5/31)",0.004072985,2.39,"Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g11002.t4","Protein Wnt-7a;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Cluster 2: cell differentiation"
"12","2",8.76,"GO:0021781","glial cell fate commitment","The process in which the developmental fate of a cell becomes restricted such that it will develop into a glial cell.","11.111% (1/9)",0.5042862,0.3,NA,NA,"33.333% (3/9)",0.003040497,2.52,"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g942.t1;Pocillopora_acuta_HIv2___TS.g11002.t4","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Cluster 2: cell differentiation"
"13","2",8.98,"GO:0008594","photoreceptor cell morphogenesis","The process in which the structures of a photoreceptor cell are generated and organized. This process occurs while the initially relatively unspecialized cell is acquiring the specialized features of a photoreceptor cell, a sensory cell that reacts to the presence of light. An example of this is found in Drosophila melanogaster.","50% (4/8)",0.001717946,2.76,"Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___TS.g1768.t1","Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","0% (0/8)",1,0,NA,NA,"Cluster 2: cell differentiation"
"14","2",9.27,"GO:0045467","R7 cell development","The process whose specific outcome is the progression of the R7 photoreceptor over time, from its formation to the mature structure. The R7 photoreceptor is the last photoreceptor to develop in the ommatidium.","66.667% (4/6)",0.0004159939,3.38,"Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___TS.g1768.t1","Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","0% (0/6)",1,0,NA,NA,"Cluster 2: cell differentiation"
"15","2",7.56,"GO:0008347","glial cell migration","The orderly movement of a glial cell, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system.","16.129% (5/31)",0.07842304,1.11,NA,NA,"19.355% (6/31)",0.0006128399,3.21,"Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g942.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12453.t2","Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-2;Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-2","Cluster 2: cell differentiation"
"16","2",8.57,"GO:0060856","establishment of blood-brain barrier","Establishment of the barrier between the blood and the brain. The cells in the brain are packed tightly together preventing the passage of most molecules from the blood into the brain. Only lipid soluble molecules or those that are actively transported can pass through the blood-brain barrier.","33.333% (4/12)",0.009533181,2.02,"Pocillopora_acuta_HIv2___RNAseq.g13060.t1;Pocillopora_acuta_HIv2___RNAseq.g21637.t1;Pocillopora_acuta_HIv2___TS.g15672.t1;Pocillopora_acuta_HIv2___TS.g19097.t2","Low-density lipoprotein receptor-related protein 6 (LRP-6);Reversion-inducing cysteine-rich protein with Kazal motifs;Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7);Neurexin-4 (Neurexin IV)","8.333% (1/12)",0.3477365,0.46,NA,NA,"Cluster 2: cell differentiation"
"17","2",8.86,"GO:0021891","olfactory bulb interneuron development","The process whose specific outcome is the progression of an interneuron residing in the olfactory bulb, from its initial commitment, to the fully functional differentiated cell.","0% (0/8)",1,0,NA,NA,"37.5% (3/8)",0.002080615,2.68,"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1","Roundabout homolog 2;Roundabout homolog 2;Roundabout homolog 1","Cluster 2: cell differentiation"
"18","3",8.35,"GO:0007297","follicle cell of egg chamber migration","The directed movement of an ovarian follicle cell that takes place during oogenesis. During egg chamber formation, follicle cells migrate to envelop the germ-line cysts and move in between cysts. At stage 10B, follicle cells migrate centripetally between the nurse cells and the oocyte, enclosing the anterior of the egg. An example of this is found in Drosophila melanogaster.","36.364% (4/11)",0.006750758,2.17,"Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___TS.g1768.t1","Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","18.182% (2/11)",0.05441731,1.26,NA,NA,"Cluster 3: anatomical structure development"
"19","3",7.76,"GO:0030707","follicle cell of egg chamber development","The process that occurs during oogenesis involving the ovarian follicle cells, somatic cells which surround the germ cells of an ovary. An example of this is found in Drosophila melanogaster.","30.769% (4/13)",1,0,NA,NA,"23.077% (3/13)",0.009330015,2.03,"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g6576.t2","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];LIM domain-containing protein jub","Cluster 3: anatomical structure development"
"20","3",9.11,"GO:0048808","male genitalia morphogenesis","The process in which the anatomical structures of male genitalia are generated and organized.","0% (0/7)",1,0,NA,NA,"42.857% (3/7)",0.001334843,2.87,"Pocillopora_acuta_HIv2___RNAseq.g2037.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4","Kelch-like protein 10;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Cluster 3: anatomical structure development"
"21","3",9.27,"GO:0035846","oviduct epithelium development","The progression of the oviduct epithelium over time from its initial formation to the mature structure. An oviduct is a tube through which an ova passes from the ovary to the uterus, or from the ovary to the outside of the organism. The oviduct epithelium is the specialized epithelium that lines the oviduct.","0% (0/6)",1,0,NA,NA,"66.667% (4/6)",2.082297e-05,4.68,"Pocillopora_acuta_HIv2___RNAseq.g21562.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g9085.t1;Pocillopora_acuta_HIv2___TS.g23391.t1","CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","Cluster 3: anatomical structure development"
"22","3",8.29,"GO:0060740","prostate gland epithelium morphogenesis","The process in which the anatomical structures of epithelia of the prostate gland are generated and organized. An epithelium consists of closely packed cells arranged in one or more layers, that covers the outer surfaces of the body or lines any internal cavity or tube.","8.333% (1/12)",0.6077395,0.22,NA,NA,"25% (3/12)",0.007365383,2.13,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","Cluster 3: anatomical structure development"
"23","3",9.45,"GO:0060739","mesenchymal-epithelial cell signaling involved in prostate gland development","Any process that mediates the transfer of information from a mesenchymal cell to an epithelial cell where it is received and interpreted contributing to the progression of the prostate gland over time.","20% (1/5)",0.3227936,0.49,NA,NA,"60% (3/5)",0.0004019195,3.4,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","Cluster 3: anatomical structure development"
"24","3",7.42,"GO:0007476","imaginal disc-derived wing morphogenesis","The process in which the anatomical structures of the imaginal disc-derived wing are generated and organized. The wing is an appendage modified for flying.","4.348% (1/23)",0.8338318,0.08,NA,NA,"17.391% (4/23)",0.007674739,2.11,"Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30706.t1","Tissue inhibitor of metalloproteinase;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]","Cluster 3: anatomical structure development"
"25","3",9.45,"GO:0060447","bud outgrowth involved in lung branching","The process in which a region of the lung epithelium initiates an outgrowth.","20% (1/5)",0.3227936,0.49,NA,NA,"60% (3/5)",0.0004019195,3.4,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","Cluster 3: anatomical structure development"
"26","3",9.45,"GO:0060745","mammary gland branching involved in pregnancy","The process in which the branching structure of the mammary gland duct is generated and organized as a part of pregnancy.","0% (0/5)",1,0,NA,NA,"60% (3/5)",0.0004019195,3.4,"Pocillopora_acuta_HIv2___RNAseq.g21562.t1;Pocillopora_acuta_HIv2___RNAseq.g9085.t1;Pocillopora_acuta_HIv2___TS.g23391.t1","CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","Cluster 3: anatomical structure development"
"27","4",7.97,"GO:1902742","apoptotic process involved in development",NA,"11.765% (2/17)",0.367972,0.43,NA,NA,"23.529% (4/17)",0.002433187,2.61,"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1","Roundabout homolog 2;Roundabout homolog 2;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5)","Cluster 4: anatomical structure development"
"28","4",9.45,"GO:0060061","Spemann organizer formation","Formation of the specialized region on the dorsalmost side of the embryo that acts as the main signaling center establishing the vertebrate body plan.","0% (0/5)",1,0,NA,NA,"60% (3/5)",0.0004019195,3.4,"Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1","Protein Wnt-8a;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5)","Cluster 4: anatomical structure development"
"29","4",8.29,"GO:0048859","formation of anatomical boundary","The process in which the limits of an anatomical structure are generated. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.","16.667% (2/12)",0.2257181,0.65,NA,NA,"25% (3/12)",0.007365383,2.13,"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30706.t1","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]","Cluster 4: anatomical structure development"
"30","4",6.16,"GO:0031099","regeneration","The regrowth of a lost or destroyed body part, such as an organ or tissue. This process may occur via renewal, repair, and/or growth alone (i.e. increase in size or mass).","10.169% (12/118)",0.173139,0.76,NA,NA,"13.559% (16/118)",0.002791943,2.55,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g9381.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Protein Wnt-7a;Protein Wnt-8b;Matrilin-2;Protein jagged-1 (Jagged1) (CD antigen CD339);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Matrilin-2;Protein Wnt-8b;Protein Wnt-8b;Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","Cluster 4: anatomical structure development"
"31","4",4.33,"GO:0048729","tissue morphogenesis","The process in which the anatomical structures of a tissue are generated and organized.","7.868% (31/394)",0.4161758,0.38,NA,NA,"9.137% (36/394)",0.001283071,2.89,"Pocillopora_acuta_HIv2___RNAseq.7335_t;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g21562.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g26270.t1a;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___RNAseq.g3088.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g9085.t1;Pocillopora_acuta_HIv2___RNAseq.g942.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g23391.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g568.t1;Pocillopora_acuta_HIv2___TS.g7543.t1","Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1);Collagen triple helix repeat-containing protein 1;Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1);Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Roundabout homolog 2;Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Nephrocystin-3;Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protein Wnt-8b;Protein Wnt-8b;CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A);SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)","Cluster 4: anatomical structure development"
"32","4",8.01,"GO:0036342","post-anal tail morphogenesis","The process in which a post-anal tail is generated and organized. A post-anal tail is a muscular region of the body that extends posterior to the anus. The post-anal tail may aid locomotion and balance.","9.524% (2/21)",0.4742934,0.32,NA,NA,"19.048% (4/21)",0.00548008,2.26,"Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Protein Wnt-8a;Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","Cluster 4: anatomical structure development"
"33","5",9.45,"GO:0071699","olfactory placode morphogenesis","The process in which the anatomical structures of the olfactory placode are generated and organized. The olfactory placode is a thickening of the neural ectoderm in the head region of the vertebrate embryo which develops into the olfactory region of the nasal cavity.","0% (0/5)",1,0,NA,NA,"60% (3/5)",0.0004019195,3.4,"Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b","Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","Cluster 5: multicellular organism development"
"34","5",8.57,"GO:0010172","embryonic body morphogenesis","The process in which the anatomical structures of the embryonic soma are generated and organized.","33.333% (4/12)",0.009533181,2.02,"Pocillopora_acuta_HIv2___RNAseq.26564_t;Pocillopora_acuta_HIv2___RNAseq.g17085.t1;Pocillopora_acuta_HIv2___RNAseq.g17089.t1;Pocillopora_acuta_HIv2___RNAseq.g17090.t1","Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2);Peroxidasin homolog pxn-2 (EC 1.11.2.-);Peroxidasin homolog pxn-2 (EC 1.11.2.-);Peroxidasin homolog pxn-2 (EC 1.11.2.-)","0% (0/12)",1,0,NA,NA,"Cluster 5: multicellular organism development"
"35","5",4.45,"GO:0048598","embryonic morphogenesis","The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants.","9.067% (35/386)",0.5313176,0.27,NA,NA,"7.513% (29/386)",0.004932873,2.31,"Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.7335_t;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___RNAseq.g3088.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g5896.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g942.t1;Pocillopora_acuta_HIv2___RNAseq.g9589.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g568.t1","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1);Fibrillin-2 [Cleaved into: Placensin];Collagen triple helix repeat-containing protein 1;Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Nephrocystin-3;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Probable N-acetyltransferase camello (EC 2.3.1.-) (Xcml);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A);Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Protein Wnt-8b;Protein Wnt-8b;Collagen alpha-1(XXVII) chain B;Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)","Cluster 5: multicellular organism development"
"36","5",6.9,"GO:0009880","embryonic pattern specification","The process that results in the patterns of cell differentiation that will arise in an embryo.","7.407% (4/54)",0.5844879,0.23,NA,NA,"12.963% (7/54)",0.002582555,2.59,"Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1","Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Protein Wnt-8b;Protein Wnt-8b","Cluster 5: multicellular organism development"
"37","5",6.42,"GO:0009953","dorsal/ventral pattern formation","The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.","6.25% (5/80)",0.7262634,0.14,NA,NA,"15% (12/80)",1.940758e-05,4.71,"Pocillopora_acuta_HIv2___RNAseq.g15163.t1;Pocillopora_acuta_HIv2___RNAseq.g22527.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g5138.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g568.t1","Noggin-2;Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid);Protein Wnt-7a;Protein Wnt-8a;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Iroquois-class homeodomain protein irx-4-A (Iroquois homeobox protein 4-A);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)","Cluster 5: multicellular organism development"
"38","5",8.49,"GO:0009954","proximal/distal pattern formation","The regionalization process in which specific areas of cell differentiation are determined along a proximal/distal axis. The proximal/distal axis is defined by a line that runs from main body (proximal end) of an organism outward (distal end).","8.333% (1/12)",0.6077395,0.22,NA,NA,"25% (3/12)",0.007365383,2.13,"Pocillopora_acuta_HIv2___RNAseq.g5138.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1","Iroquois-class homeodomain protein irx-4-A (Iroquois homeobox protein 4-A);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","Cluster 5: multicellular organism development"
"39","5",8.76,"GO:0033339","pectoral fin development","The process whose specific outcome is the progression of the pectoral fin over time, from its formation to the mature structure.","0% (0/10)",1,0,NA,NA,"30% (3/10)",0.004231833,2.37,"Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b","Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","Cluster 5: multicellular organism development"
"40","5",7.5,"GO:0002164","larval development","The process whose specific outcome is the progression of the larva over time, from its formation to the mature structure. The larva is the early, immature form of an that at birth or hatching is fundamentally unlike its parent and must metamorphose before assuming the adult characters.","7.692% (2/26)",0.5907566,0.23,NA,NA,"23.077% (6/26)",0.0002220853,3.65,"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28575.t1a;Pocillopora_acuta_HIv2___RNAseq.g28577.t1;Pocillopora_acuta_HIv2___RNAseq.g3509.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30706.t1","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]","Cluster 5: multicellular organism development"
"41","5",9.45,"GO:0048582","positive regulation of post-embryonic development","Any process that activates or increases the frequency, rate or extent of post-embryonic development. Post-embryonic development is defined as the process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure.","0% (0/5)",1,0,NA,NA,"60% (3/5)",0.0004019195,3.4,"Pocillopora_acuta_HIv2___RNAseq.g2110.t1;Pocillopora_acuta_HIv2___RNAseq.g28575.t1a;Pocillopora_acuta_HIv2___RNAseq.g28577.t1","Arginine-specific demethylase JMJ22 (EC 1.14.11.-) (Arginine-specific histone demethylase JMJ22) (F-box protein JMJ22) (Jumonji domain-containing protein 22) (AtJMJ22) (Protein JUMONJI 22) ([histone H4]-dimethyl-L-arginine(3) monodemethylase JMJ22);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)","Cluster 5: multicellular organism development"
"42","6",9.11,"GO:0043049","otic placode formation","The initial developmental process that will lead to the formation of the vertebrate inner ear. The otic placode forms as a thickening of the head ectoderm adjacent to the developing hindbrain.","28.571% (2/7)",0.09161608,1.04,NA,NA,"42.857% (3/7)",0.001334843,2.87,"Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1","Protein Wnt-8b;Protein Wnt-8b;Protein Wnt-8b","Cluster 6: sensory organ development"
"43","6",7.73,"GO:0048596","embryonic camera-type eye morphogenesis","The process in which the anatomical structures of the eye are generated and organized during embryonic development.","24% (6/25)",0.00897285,2.05,"Pocillopora_acuta_HIv2___RNAseq.22067_t;Pocillopora_acuta_HIv2___RNAseq.26564_t;Pocillopora_acuta_HIv2___RNAseq.g13060.t1;Pocillopora_acuta_HIv2___RNAseq.g27673.t1;Pocillopora_acuta_HIv2___RNAseq.g28466.t1;Pocillopora_acuta_HIv2___RNAseq.g3837.t1a","Protein Wnt-2b;Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2);Low-density lipoprotein receptor-related protein 6 (LRP-6);Paired box protein Pax-6 (Oculorhombin);Ephrin-B2a;Paired box protein Pax-2a (No isthmus protein) (Pax[Zf-b])","20% (5/25)",0.1514053,0.82,NA,NA,"Cluster 6: sensory organ development"
"44","6",9.45,"GO:0060898","eye field cell fate commitment involved in camera-type eye formation","The commitment of neurectodermal cells to cells of the eye field and their capacity to differentiate into eye field cells. Eye field cells are neurectodermal cells that will form the optic placode.","0% (0/5)",1,0,NA,NA,"60% (3/5)",0.0004019195,3.4,"Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1","Protein Wnt-8b;Protein Wnt-8b;Protein Wnt-8b","Cluster 6: sensory organ development"
"45","6",8.86,"GO:0042067","establishment of ommatidial planar polarity","The specification of polarized ommatidia. Ommatidia occur in two chiral forms. The trapezoidal arrangement of photoreceptors in the dorsal part of the eye is the mirror image of that in the ventral part.","0% (0/7)",1,0,NA,NA,"42.857% (3/7)",0.001334843,2.87,"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30706.t1","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]","Cluster 6: sensory organ development"
"46","6",6.15,"GO:0060041","retina development in camera-type eye","The process whose specific outcome is the progression of the retina over time, from its formation to the mature structure. The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates.","15.789% (15/95)",0.004501865,2.35,"Pocillopora_acuta_HIv2___RNAseq.22067_t;Pocillopora_acuta_HIv2___RNAseq.26564_t;Pocillopora_acuta_HIv2___RNAseq.g11960.t1;Pocillopora_acuta_HIv2___RNAseq.g13060.t1;Pocillopora_acuta_HIv2___RNAseq.g13533.t1;Pocillopora_acuta_HIv2___RNAseq.g13970.t2;Pocillopora_acuta_HIv2___RNAseq.g22366.t1;Pocillopora_acuta_HIv2___RNAseq.g25248.t1a;Pocillopora_acuta_HIv2___RNAseq.g27673.t1;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g3580.t1;Pocillopora_acuta_HIv2___RNAseq.g8004.t1;Pocillopora_acuta_HIv2___RNAseq.g8093.t1;Pocillopora_acuta_HIv2___TS.g15672.t1;Pocillopora_acuta_HIv2___TS.g19999.t1","Protein Wnt-2b;Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2);Trafficking protein particle complex subunit 11 (Protein foie gras);Low-density lipoprotein receptor-related protein 6 (LRP-6);Protein sidekick-2;Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein);Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X) (Lis-X);U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31);Paired box protein Pax-6 (Oculorhombin);Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48);Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein);Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7);Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7);Retinal homeobox protein Rx2","5.263% (5/95)",0.2383985,0.62,NA,NA,"Cluster 6: sensory organ development"
"47","6",7.45,"GO:0002088","lens development in camera-type eye","The process whose specific outcome is the progression of the lens over time, from its formation to the mature structure. The lens is a transparent structure in the eye through which light is focused onto the retina. An example of this process is found in Mus musculus.","23.529% (8/34)",0.003026796,2.52,"Pocillopora_acuta_HIv2___RNAseq.22067_t;Pocillopora_acuta_HIv2___RNAseq.26564_t;Pocillopora_acuta_HIv2___RNAseq.g11345.t1;Pocillopora_acuta_HIv2___RNAseq.g27673.t1;Pocillopora_acuta_HIv2___RNAseq.g2995.t1;Pocillopora_acuta_HIv2___RNAseq.g3743.t1;Pocillopora_acuta_HIv2___RNAseq.g7553.t1;Pocillopora_acuta_HIv2___TS.g9752.t3","Protein Wnt-2b;Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2);Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod);Paired box protein Pax-6 (Oculorhombin);Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a);Protein sprouty homolog 2 (Spry-2);Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form];Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]","2.941% (1/34)",0.7024383,0.15,NA,NA,"Cluster 6: sensory organ development"
"48","7",8.17,"GO:0003180","aortic valve morphogenesis","The process in which the structure of the aortic valve is generated and organized.","0% (0/18)",1,0,NA,NA,"22.222% (4/18)",0.003043188,2.52,"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1","Roundabout homolog 2;Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Roundabout homolog 1","Cluster 7: anatomical structure development"
"49","7",8.23,"GO:0003184","pulmonary valve morphogenesis","The process in which the structure of the pulmonary valve is generated and organized.","0% (0/17)",1,0,NA,NA,"29.412% (5/17)",0.0002216604,3.65,"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1","Roundabout homolog 2;Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339)","Cluster 7: anatomical structure development"
"50","7",9.45,"GO:0003129","heart induction","The close range interaction between mesoderm and endoderm or ectoderm that causes cells to change their fates and specify the development of the heart.","0% (0/5)",1,0,NA,NA,"60% (3/5)",0.0004019195,3.4,"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1","Roundabout homolog 2;Roundabout homolog 2;Roundabout homolog 1","Cluster 7: anatomical structure development"
"51","7",8.66,"GO:1905207","regulation of cardiocyte differentiation",NA,"0% (0/11)",1,0,NA,NA,"27.273% (3/11)",0.005669355,2.25,"Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4","Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Cluster 7: anatomical structure development"
"52","7",8.66,"GO:0010002","cardioblast differentiation","The process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.","0% (0/11)",1,0,NA,NA,"27.273% (3/11)",0.005669355,2.25,"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___TS.g11002.t4","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Cluster 7: anatomical structure development"
"53","7",7.45,"GO:0042475","odontogenesis of dentin-containing tooth","The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.","12.121% (4/33)",0.2321476,0.63,NA,NA,"15.152% (5/33)",0.005374192,2.27,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","Cluster 7: anatomical structure development"
"54","7",8.49,"GO:0043589","skin morphogenesis","The process in which the anatomical structures of the skin are generated and organized. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner, sensitive and vascular dermis (cutis, corium or true skin) composed mostly of connective tissue.","0% (0/13)",1,0,NA,NA,"53.846% (7/13)",8.586234e-08,7.07,"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b","Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","Cluster 7: anatomical structure development"
"55","7",3.81,"GO:0009887","animal organ morphogenesis","Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.","9.667% (58/600)",0.4314245,0.37,NA,NA,"9% (54/600)",0.004081833,2.39,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g2037.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g21562.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g26270.t1a;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27337.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9085.t1;Pocillopora_acuta_HIv2___RNAseq.g9588.t1;Pocillopora_acuta_HIv2___RNAseq.g9589.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g23391.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g3883.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g5338.t1;Pocillopora_acuta_HIv2___TS.g568.t1","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Protocadherin Fat 3 (FAT tumor suppressor homolog 3);Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Tissue inhibitor of metalloproteinase;Fibrillin-2 [Cleaved into: Placensin];Collagen triple helix repeat-containing protein 1;Kelch-like protein 10;Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1);Protein Wnt-7a;Protein Wnt-8b;Transcription factor HES-4 (Hairy and enhancer of split 4) (Protein hairy-2);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Roundabout homolog 2;Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b);Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protein Wnt-8b;Protein Wnt-8b;Collagen alpha-1(XXVII) chain B;CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Cysteine-rich protein 1 (CRP-1) (Cysteine-rich heart protein) (CRHP) (hCRHP) (Cysteine-rich intestinal protein) (CRIP);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)","Cluster 7: anatomical structure development"
"56","7",8.11,"GO:0034505","tooth mineralization","The process in which calcium salts are deposited into calcareous tooth structures such as dental enamel, dentin and cementum.","36.842% (7/19)",0.0002929594,3.53,"Pocillopora_acuta_HIv2___RNAseq.26564_t;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1","Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","0% (0/19)",1,0,NA,NA,"Cluster 7: anatomical structure development"
"57","7",7.09,"GO:0030282","bone mineralization","The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue.","12% (6/50)",0.1691743,0.77,NA,NA,"18% (9/50)",4.94349e-05,4.31,"Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g3780.t1;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g5338.t1","Fibrillin-2 [Cleaved into: Placensin];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Protein kinase C-binding protein NELL1 (NEL-like protein 1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XXVII) chain B;Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)","Cluster 7: anatomical structure development"
"58","7",8.66,"GO:0072070","loop of Henle development","The process whose specific outcome is the progression of the loop of Henle over time, from its formation to the mature structure. The loop of Henle is a nephron tubule that connects the proximal convoluted tubule to the distal convoluted tubule.","0% (0/10)",1,0,NA,NA,"30% (3/10)",0.004231833,2.37,"Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339)","Cluster 7: anatomical structure development"
"59","7",7.13,"GO:0001656","metanephros development","The process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. In mammals, the metanephros is the excretory organ of the fetus, which develops into the mature kidney and is formed from the rear portion of the nephrogenic cord. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine.","2.941% (1/34)",0.9296814,0.03,NA,NA,"17.647% (6/34)",0.001024855,2.99,"Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___TS.g23602.t1","Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Roundabout homolog 2;Roundabout homolog 2;Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","Cluster 7: anatomical structure development"
"60","7",8.23,"GO:0060384","innervation","The process in which a nerve invades a tissue and makes functional synaptic connection within the tissue.","29.412% (5/17)",0.006763678,2.17,"Pocillopora_acuta_HIv2___RNAseq.g13400.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g2263.t1b;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g8093.t1","Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7)","5.882% (1/17)",0.454206,0.34,NA,NA,"Cluster 7: anatomical structure development"
"61","7",7.32,"GO:0021545","cranial nerve development","The process whose specific outcome is the progression of the cranial nerves over time, from its formation to the mature structure. The cranial nerves are composed of twelve pairs of nerves that emanate from the nervous tissue of the hindbrain. These nerves are sensory, motor, or mixed in nature, and provide the motor and general sensory innervation of the head, neck and viscera. They mediate vision, hearing, olfaction and taste and carry the parasympathetic innervation of the autonomic ganglia that control visceral functions.","30.769% (8/26)",0.0004446361,3.35,"Pocillopora_acuta_HIv2___RNAseq.26564_t;Pocillopora_acuta_HIv2___RNAseq.665_t;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g13400.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g8093.t1","Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2);POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase);Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7)","11.538% (3/26)",0.06082704,1.22,NA,NA,"Cluster 7: anatomical structure development"
"62","7",6.85,"GO:0021549","cerebellum development","The process whose specific outcome is the progression of the cerebellum over time, from its formation to the mature structure. The cerebellum is the portion of the brain in the back of the head between the cerebrum and the pons. In mice, the cerebellum controls balance for walking and standing, modulates the force and range of movement and is involved in the learning of motor skills.","17.544% (10/57)",0.009085095,2.04,"Pocillopora_acuta_HIv2___RNAseq.g11589.t1;Pocillopora_acuta_HIv2___RNAseq.g13060.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g27673.t1;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___RNAseq.g3482.t1;Pocillopora_acuta_HIv2___RNAseq.g3837.t1a;Pocillopora_acuta_HIv2___TS.g18947.t1","All trans-polyprenyl-diphosphate synthase PDSS2 (All-trans-decaprenyl-diphosphate synthase subunit 2) (EC 2.5.1.91) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2) (Decaprenyl-diphosphate synthase subunit 2) (Solanesyl-diphosphate synthase subunit 2);Low-density lipoprotein receptor-related protein 6 (LRP-6);Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Paired box protein Pax-6 (Oculorhombin);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Polycomb complex protein BMI-1-A (Polycomb group RING finger protein 4-A);Paired box protein Pax-2a (No isthmus protein) (Pax[Zf-b]);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)","1.754% (1/57)",0.8692703,0.06,NA,NA,"Cluster 7: anatomical structure development"
"63","7",8.86,"GO:0021854","hypothalamus development","The progression of the hypothalamus region of the forebrain, from its initial formation to its mature state.","11.111% (1/9)",0.5042862,0.3,NA,NA,"33.333% (3/9)",0.003040497,2.52,"Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1","Protein Wnt-8b;Protein Wnt-8b;Protein Wnt-8b","Cluster 7: anatomical structure development"
"64","7",7.47,"GO:0035904","aorta development","The progression of the aorta over time, from its initial formation to the mature structure. An aorta is an artery that carries blood from the heart to other parts of the body.","13.889% (5/36)",0.128864,0.89,NA,NA,"16.667% (6/36)",0.001399593,2.85,"Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1","Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Roundabout homolog 2;Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339)","Cluster 7: anatomical structure development"
"65","7",7.21,"GO:0031018","endocrine pancreas development","The process whose specific outcome is the progression of the endocrine pancreas over time, from its formation to the mature structure. The endocrine pancreas is made up of islet cells that produce insulin, glucagon and somatostatin.","24% (6/25)",0.00897285,2.05,"Pocillopora_acuta_HIv2___RNAseq.g14060.t1;Pocillopora_acuta_HIv2___RNAseq.g16957.t1;Pocillopora_acuta_HIv2___RNAseq.g25869.t1;Pocillopora_acuta_HIv2___RNAseq.g27673.t1;Pocillopora_acuta_HIv2___RNAseq.g28270.t1;Pocillopora_acuta_HIv2___RNAseq.g9027.t1","Insulinoma-associated protein 1 (Zinc finger protein IA-1);Transcription factor SOX-4;DNA-binding protein RFX6 (Regulatory factor X 6);Paired box protein Pax-6 (Oculorhombin);Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK);Bone morphogenetic protein 6 (BMP-6) (VG-1-related protein) (VG-1-R) (VGR-1)","4% (1/25)",0.5896906,0.23,NA,NA,"Cluster 7: anatomical structure development"
"66","7",6.05,"GO:0051216","cartilage development","The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.","6% (6/100)",0.7703893,0.11,NA,NA,"11% (11/100)",0.0007098826,3.15,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g13857.t1;Pocillopora_acuta_HIv2___RNAseq.g15163.t1;Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g5338.t1","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Bone morphogenetic protein 2 (BMP-2);Noggin-2;Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Protein Wnt-7a;Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)","Cluster 7: anatomical structure development"
"67","7",4.94,"GO:0048880","sensory system development","The process whose specific outcome is the progression of a sensory system over time from its formation to the mature structure.","13.158% (35/266)",0.5331955,0.27,NA,NA,"8.647% (23/266)",0.006625817,2.18,"Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g27337.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g3832.t1;Pocillopora_acuta_HIv2___RNAseq.g434.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g9588.t1;Pocillopora_acuta_HIv2___RNAseq.g9589.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b","Protocadherin Fat 3 (FAT tumor suppressor homolog 3);Fibrillin-2 [Cleaved into: Placensin];Protein Wnt-8b;Protein Wnt-8a;Transcription factor HES-4 (Hairy and enhancer of split 4) (Protein hairy-2);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Diencephalon/mesencephalon homeobox protein 1-B;Frizzled-5 (Fz-5) (Xfz5);Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Protein jagged-1 (Jagged1) (CD antigen CD339);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b);Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protein Wnt-8b;Protein Wnt-8b;Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","Cluster 7: anatomical structure development"
"68","7",5.05,"GO:0001501","skeletal system development","The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).","5.833% (14/240)",0.8701362,0.06,NA,NA,"10.833% (26/240)",8.330354e-05,4.08,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g13857.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g15163.t1;Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g30131.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g5338.t1","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Bone morphogenetic protein 2 (BMP-2);Fibrillin-2 [Cleaved into: Placensin];Noggin-2;Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Protein Wnt-7a;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XXVII) chain B;Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)","Cluster 7: anatomical structure development"
"69","7",8.35,"GO:0007447","imaginal disc pattern formation","The regionalization process that results in defined areas of the imaginal disc that will undergo specific cell differentaiton. Imaginal discs are epithelial infoldings in the larvae of holometabolous insects that develop into adult appendages (legs, antennae, wings, etc.) during metamorphosis from larval to adult form.","9.091% (1/11)",0.5759044,0.24,NA,NA,"27.273% (3/11)",0.005669355,2.25,"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30706.t1","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]","Cluster 7: anatomical structure development"
"70","7",7.45,"GO:0003197","endocardial cushion development","The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.","0% (0/29)",1,0,NA,NA,"17.241% (5/29)",0.003013915,2.52,"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1","Roundabout homolog 2;Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339)","Cluster 7: anatomical structure development"
"71","8",8.98,"GO:0019755","one-carbon compound transport","The directed movement of one-carbon compounds into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.","0% (0/8)",1,0,NA,NA,"37.5% (3/8)",0.002080615,2.68,"Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g19887.t1","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)","Cluster 8: transport"
"72","8",7.59,"GO:1902476","chloride transmembrane transport",NA,"28.125% (9/32)",0.0004148913,3.38,"Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g17622.t1;Pocillopora_acuta_HIv2___RNAseq.g19042.t1;Pocillopora_acuta_HIv2___RNAseq.g19043.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g22644.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln));Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G);Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit)","6.25% (2/32)",0.3086406,0.51,NA,NA,"Cluster 8: transport"
"73","8",9.45,"GO:0045117","azole transmembrane transport","The directed movement of azoles, heterocyclic compounds found in many biologically important substances, across a lipid bilayer, across a membrane.","60% (3/5)",0.003742425,2.43,"Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___RNAseq.g25241.t1;Pocillopora_acuta_HIv2___TS.g9513.t1","High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29);Carcinine transporter","0% (0/5)",1,0,NA,NA,"Cluster 8: transport"
"74","8",8.98,"GO:0015881","creatine transmembrane transport","The directed movement of creatine across a membrane.","50% (4/8)",0.001717946,2.76,"Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g26586.t1;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1","Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","12.5% (1/8)",0.2478429,0.61,NA,NA,"Cluster 8: transport"
"75","8",7.62,"GO:0089718","amino acid import across plasma membrane","The directed movement of an amino acid from outside of a cell, across the plasma membrane and into the cytosol.","50% (8/16)",7.192388e-06,5.14,"Pocillopora_acuta_HIv2___RNAseq.25384_t;Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___RNAseq.g22644.t1;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1;Pocillopora_acuta_HIv2___TS.g5171.t1","Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","0% (0/16)",1,0,NA,NA,"Cluster 8: transport"
"76","8",9.27,"GO:1903352","L-ornithine transmembrane transport",NA,"66.667% (4/6)",0.0004159939,3.38,"Pocillopora_acuta_HIv2___RNAseq.25384_t;Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___RNAseq.g25241.t1;Pocillopora_acuta_HIv2___TS.g5171.t1","Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29);Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","0% (0/6)",1,0,NA,NA,"Cluster 8: transport"
"77","8",8.76,"GO:1903826","L-arginine transmembrane transport",NA,"50% (5/10)",0.0004283556,3.37,"Pocillopora_acuta_HIv2___RNAseq.g14744.t1;Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___RNAseq.g21527.t1;Pocillopora_acuta_HIv2___RNAseq.g25241.t1;Pocillopora_acuta_HIv2___TS.g5171.t1","Protein btn-1;High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);Protein BTN1;Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29);Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","0% (0/10)",1,0,NA,NA,"Cluster 8: transport"
"78","8",8.57,"GO:0051939","gamma-aminobutyric acid import","The directed movement of gamma-aminobutyric acid (GABA, 4-aminobutyrate) into a cell or organelle.","33.333% (4/12)",0.009533181,2.02,"Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1","Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","16.667% (2/12)",0.0638277,1.19,NA,NA,"Cluster 8: transport"
"79","8",8.86,"GO:0042883","cysteine transport","The directed movement of cysteine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.","44.444% (4/9)",0.002909709,2.54,"Pocillopora_acuta_HIv2___RNAseq.g22644.t1;Pocillopora_acuta_HIv2___RNAseq.g7215.t1;Pocillopora_acuta_HIv2___RNAseq.g7217.t1;Pocillopora_acuta_HIv2___TS.g22105.t1","Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);Major facilitator superfamily domain-containing protein 12 (Protein grizzled);Major facilitator superfamily domain-containing protein 12 (Protein grizzled);Major facilitator superfamily domain-containing protein 12","0% (0/9)",1,0,NA,NA,"Cluster 8: transport"
"80","8",9.11,"GO:1902022","L-lysine transport",NA,"71.429% (5/7)",4.321628e-05,4.36,"Pocillopora_acuta_HIv2___RNAseq.25384_t;Pocillopora_acuta_HIv2___RNAseq.g14744.t1;Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___RNAseq.g21527.t1;Pocillopora_acuta_HIv2___RNAseq.g25241.t1","Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);Protein btn-1;High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);Protein BTN1;Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29)","0% (0/7)",1,0,NA,NA,"Cluster 8: transport"
"81","9",7.59,"GO:0006826","iron ion transport","The directed movement of iron (Fe) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.","7.143% (2/28)",0.631649,0.2,NA,NA,"17.857% (5/28)",0.002566582,2.59,"Pocillopora_acuta_HIv2___RNAseq.g14366.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g4878.t1;Pocillopora_acuta_HIv2___TS.g12848.t1","Scavenger receptor class A member 5;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228);Scavenger receptor class A member 5","Cluster 9: transport"
"82","9",6.29,"GO:0006814","sodium ion transport","The directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.","15.476% (13/84)",0.009327027,2.03,"Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g14817.t1;Pocillopora_acuta_HIv2___RNAseq.g18121.t1;Pocillopora_acuta_HIv2___RNAseq.g24029.t1;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g30992.t1;Pocillopora_acuta_HIv2___RNAseq.g30994.t1a;Pocillopora_acuta_HIv2___RNAseq.g898.t1b;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1;Pocillopora_acuta_HIv2___TS.g21128.t1","Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Kelch-like protein 3;Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2);Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA);Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3);Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2);RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b)","5.952% (5/84)",0.1702722,0.77,NA,NA,"Cluster 9: transport"
"83","9",5.43,"GO:0006816","calcium ion transport","The directed movement of calcium (Ca) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.","13.423% (20/149)",0.007691142,2.11,"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g18121.t1;Pocillopora_acuta_HIv2___RNAseq.g1838.t1;Pocillopora_acuta_HIv2___RNAseq.g19392.t1;Pocillopora_acuta_HIv2___RNAseq.g24761.t1;Pocillopora_acuta_HIv2___RNAseq.g26118.t1;Pocillopora_acuta_HIv2___RNAseq.g26672.t1;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g2813.t4;Pocillopora_acuta_HIv2___RNAseq.g28270.t1;Pocillopora_acuta_HIv2___RNAseq.g4919.t1;Pocillopora_acuta_HIv2___RNAseq.g5755.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g8093.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___TS.g14552.t1;Pocillopora_acuta_HIv2___TS.g28111.t1","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);Adenosine receptor A2a;Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2);m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1);1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2);Annexin A6 (Annexin VI) (Annexin-6);Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein);Neuronal acetylcholine receptor subunit alpha-7;Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46);Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Cadherin-23 (Otocadherin);F-box only protein 11","2.013% (3/149)",0.8979354,0.05,NA,NA,"Cluster 9: transport"
"84","9",8.49,"GO:1901016","regulation of potassium ion transmembrane transporter activity",NA,"7.692% (1/13)",0.637188,0.2,NA,NA,"23.077% (3/13)",0.009330015,2.03,"Pocillopora_acuta_HIv2___RNAseq.g16285.t1;Pocillopora_acuta_HIv2___RNAseq.g23588.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b","Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","Cluster 9: transport"
"85","9",4.97,"GO:0098662","inorganic cation transmembrane transport","A process in which an inorganic cation is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.","12.681% (35/276)",0.00144231,2.84,"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.18284_t;Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g14489.t1;Pocillopora_acuta_HIv2___RNAseq.g15097.t1;Pocillopora_acuta_HIv2___RNAseq.g16474.t1;Pocillopora_acuta_HIv2___RNAseq.g17559.t1;Pocillopora_acuta_HIv2___RNAseq.g17622.t1;Pocillopora_acuta_HIv2___RNAseq.g18121.t1;Pocillopora_acuta_HIv2___RNAseq.g1838.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g19392.t1;Pocillopora_acuta_HIv2___RNAseq.g2273.t1;Pocillopora_acuta_HIv2___RNAseq.g24029.t1;Pocillopora_acuta_HIv2___RNAseq.g24761.t1;Pocillopora_acuta_HIv2___RNAseq.g26118.t1;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g28270.t1;Pocillopora_acuta_HIv2___RNAseq.g28816.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g29670.t2;Pocillopora_acuta_HIv2___RNAseq.g4469.t1;Pocillopora_acuta_HIv2___RNAseq.g4919.t1;Pocillopora_acuta_HIv2___RNAseq.g5755.t1;Pocillopora_acuta_HIv2___RNAseq.g6094.t2;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g8093.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1;Pocillopora_acuta_HIv2___TS.g21128.t1;Pocillopora_acuta_HIv2___TS.g28111.t1","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);Putative ammonium transporter 3;Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Transmembrane protein 94 (Endoplasmic reticulum magnesium ATPase);Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8);Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (NKCC1) (Na-K-CL symporter);TWiK family of potassium channels protein 7;Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln));Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2);m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2);Putative ammonium transporter 1;Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA);Annexin A6 (Annexin VI) (Annexin-6);Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein);Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK);Proton-coupled zinc antiporter SLC30A8 (Solute carrier family 30 member 8) (Zinc transporter 8) (ZnT-8);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3);Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b);F-box only protein 11","3.261% (9/276)",0.8990524,0.05,NA,NA,"Cluster 9: transport"
"86","9",4.96,"GO:0098655","monoatomic cation transmembrane transport","The process in which a monoatomic cation is transported across a membrane. Monatomic cations (also called simple cations) are positively charged ions consisting of exactly one atom.","12.23% (34/278)",0.003059632,2.51,"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g14489.t1;Pocillopora_acuta_HIv2___RNAseq.g15097.t1;Pocillopora_acuta_HIv2___RNAseq.g16474.t1;Pocillopora_acuta_HIv2___RNAseq.g17559.t1;Pocillopora_acuta_HIv2___RNAseq.g17622.t1;Pocillopora_acuta_HIv2___RNAseq.g18121.t1;Pocillopora_acuta_HIv2___RNAseq.g1838.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g19392.t1;Pocillopora_acuta_HIv2___RNAseq.g24029.t1;Pocillopora_acuta_HIv2___RNAseq.g24761.t1;Pocillopora_acuta_HIv2___RNAseq.g26118.t1;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g2813.t4;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g28270.t1;Pocillopora_acuta_HIv2___RNAseq.g28816.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g29670.t2;Pocillopora_acuta_HIv2___RNAseq.g4469.t1;Pocillopora_acuta_HIv2___RNAseq.g4919.t1;Pocillopora_acuta_HIv2___RNAseq.g5755.t1;Pocillopora_acuta_HIv2___RNAseq.g6094.t2;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g8093.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1;Pocillopora_acuta_HIv2___TS.g21128.t1;Pocillopora_acuta_HIv2___TS.g28111.t1","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Transmembrane protein 94 (Endoplasmic reticulum magnesium ATPase);Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8);Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (NKCC1) (Na-K-CL symporter);TWiK family of potassium channels protein 7;Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln));Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2);m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2);Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA);Annexin A6 (Annexin VI) (Annexin-6);Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein);Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK);Proton-coupled zinc antiporter SLC30A8 (Solute carrier family 30 member 8) (Zinc transporter 8) (ZnT-8);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3);Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b);F-box only protein 11","3.237% (9/278)",0.9028862,0.04,NA,NA,"Cluster 9: transport"
"87","10",7.53,"GO:0085029","extracellular matrix assembly","The aggregation, arrangement and bonding together of the extracellular matrix.","0% (0/32)",1,0,NA,NA,"18.75% (6/32)",0.0007323821,3.14,"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15832.t1","Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Cluster 10: external encapsulating structure organization"
"88","10",5.34,"GO:0045229","external encapsulating structure organization","A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of external structures that lie outside the plasma membrane and surround the entire cell.","10.55% (23/218)",0.0598292,1.22,NA,NA,"16.514% (36/218)",0.001096047,2.96,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g16526.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g20718.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24766.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g1340.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g24066.t1;Pocillopora_acuta_HIv2___TS.g5338.t1","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Hemicentin-1 (Fibulin-6) (FIBL-6);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Tissue inhibitor of metalloproteinase;Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-4(VI) chain;Cell wall protein DAN4 (Delayed anaerobic protein 4);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Probable glycosyltransferase STELLO2 (EC 2.4.-.-);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Papilin;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-4 (MAT-4);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-2;Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-2;Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Collagen alpha-1(XXVII) chain B;Collagen alpha-2(IV) chain;Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)","Cluster 10: external encapsulating structure organization"
"89","10",7.21,"GO:0030199","collagen fibril organization","Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.","2.326% (1/43)",0.9652334,0.02,NA,NA,"13.953% (6/43)",0.003568792,2.45,"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15832.t1","Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Cluster 10: external encapsulating structure organization"
"90","10",5.41,"GO:0030198","extracellular matrix organization","A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.","10.837% (22/203)",0.05088716,1.29,NA,NA,"15.764% (32/203)",2.799134e-08,7.55,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24766.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g1340.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g24066.t1;Pocillopora_acuta_HIv2___TS.g5338.t1","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Hemicentin-1 (Fibulin-6) (FIBL-6);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Tissue inhibitor of metalloproteinase;Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-4(VI) chain;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Papilin;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-4 (MAT-4);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-2;Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Matrilin-2;Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Collagen alpha-1(XXVII) chain B;Collagen alpha-2(IV) chain;Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)","Cluster 10: external encapsulating structure organization"
"91","10",6.68,"GO:0071711","basement membrane organization","A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the basement membrane.","14.286% (9/63)",0.04411205,1.36,NA,NA,"15.873% (10/63)",5.852342e-05,4.23,"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g17199.t1","Hemicentin-1 (Fibulin-6) (FIBL-6);Tissue inhibitor of metalloproteinase;Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha)","Cluster 10: external encapsulating structure organization"
"92","11",8.76,"GO:0097104","postsynaptic membrane assembly","The aggregation, arrangement and bonding together of a set of components to form a postsynaptic membrane, a specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft).","12.5% (1/8)",0.4640687,0.33,NA,NA,"37.5% (3/8)",0.002080615,2.68,"Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1","Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","Cluster 11: biological_process"
"93","11",8.35,"GO:0097105","presynaptic membrane assembly","The aggregation, arrangement and bonding together of a set of components to form a presynaptic membrane, including any proteins associated with the membrane, but excluding other cellular components. A presynaptic membrane is a specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction.","13.333% (2/15)",0.3116574,0.51,NA,NA,"33.333% (5/15)",0.0001139688,3.94,"Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1","Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","Cluster 11: biological_process"
"94","11",7.69,"GO:0099054","presynapse assembly","The aggregation, arrangement and bonding together of a set of components to form a presynapse.","8.333% (2/24)",0.5465765,0.26,NA,NA,"33.333% (8/24)",0.002924913,2.53,"Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1","Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Protein Wnt-7a;Frizzled-5 (Fz-5);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","Cluster 11: biological_process"
"95","11",6,"GO:1901888","regulation of cell junction assembly",NA,"2.239% (3/134)",0.9980498,0,NA,NA,"11.94% (16/134)",0.002112258,2.68,"Pocillopora_acuta_HIv2___RNAseq.673_t;Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1","LHFPL tetraspan subfamily member 4 protein (Lipoma HMGIC fusion partner-like 4 protein);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Protein Wnt-7a;Roundabout homolog 2;Roundabout homolog 2;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Roundabout homolog 1;Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","Cluster 11: biological_process"
"96","11",7.56,"GO:0051965","positive regulation of synapse assembly","Any process that activates, maintains or increases the frequency, rate or extent of synapse assembly, the aggregation, arrangement and bonding together of a set of components to form a synapse.","3.125% (1/32)",0.917774,0.04,NA,NA,"18.75% (6/32)",0.0007323821,3.14,"Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1","Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Protein Wnt-7a;Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","Cluster 11: biological_process"
"97","11",8.66,"GO:0099151","regulation of postsynaptic density assembly","Any process that modulates the frequency, rate or extent of postsynaptic density assembly, the aggregation, arrangement and bonding together of a set of components to form a postsynaptic density.","0% (0/11)",1,0,NA,NA,"27.273% (3/11)",0.005669355,2.25,"Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1","Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","Cluster 11: biological_process"
"98","11",7.84,"GO:0099560","synaptic membrane adhesion","The attachment of presynaptic membrane to postsynaptic membrane via adhesion molecules that are at least partially embedded in the plasma membrane.","0% (0/24)",1,0,NA,NA,"29.167% (7/24)",1.241093e-05,4.91,"Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g8259.t1b","Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Protein turtle homolog B (Immunoglobulin superfamily member 9B);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)","Cluster 11: biological_process"
"99","11",4.73,"GO:0050808","synapse organization","A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).","8.228% (26/316)",0.3384714,0.47,NA,NA,"10.127% (32/316)",0.001814772,2.74,"Pocillopora_acuta_HIv2___RNAseq.673_t;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g28252.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7219.t1;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g29912.t2;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g8131.t1;Pocillopora_acuta_HIv2___TS.g8258.t1;Pocillopora_acuta_HIv2___TS.g8259.t1b","LHFPL tetraspan subfamily member 4 protein (Lipoma HMGIC fusion partner-like 4 protein);Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Hemicentin-2;Hemicentin-2;Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Protein Wnt-7a;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Roundabout homolog 2;Roundabout homolog 2;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Roundabout homolog 1;Cortactin-binding protein 2 (CortBP2);Protein turtle homolog B (Immunoglobulin superfamily member 9B);Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Hemicentin-2;E3 ubiquitin-protein ligase PDZRN3-B (EC 2.3.2.27) (PDZ domain-containing RING finger protein 3-B);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158);Hemicentin-2;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)","Cluster 11: biological_process"
"100","11",8.49,"GO:1904395","positive regulation of skeletal muscle acetylcholine-gated channel clustering",NA,"15.385% (2/13)",0.2543576,0.59,NA,NA,"23.077% (3/13)",0.009330015,2.03,"Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b","Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","Cluster 11: biological_process"
"101","11",8.98,"GO:0036309","protein localization to M-band","Any process in which a protein is transported to, and/or maintained in, the M band. The M band is the midline of aligned thick filaments in a sarcomere.","12.5% (1/8)",0.4640687,0.33,NA,NA,"37.5% (3/8)",0.002080615,2.68,"Pocillopora_acuta_HIv2___RNAseq.g16285.t1;Pocillopora_acuta_HIv2___RNAseq.g23588.t1;Pocillopora_acuta_HIv2___TS.g15585.t1","Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)","Cluster 11: biological_process"
"102","11",5.64,"GO:0170033","L-amino acid metabolic process",NA,"13.423% (20/149)",0.007691142,2.11,"Pocillopora_acuta_HIv2___RNAseq.g10854.t2;Pocillopora_acuta_HIv2___RNAseq.g11840.t1;Pocillopora_acuta_HIv2___RNAseq.g1504.t1;Pocillopora_acuta_HIv2___RNAseq.g16699.t1;Pocillopora_acuta_HIv2___RNAseq.g19367.t1;Pocillopora_acuta_HIv2___RNAseq.g23634.t1;Pocillopora_acuta_HIv2___RNAseq.g26341.t1;Pocillopora_acuta_HIv2___RNAseq.g26474.t1a;Pocillopora_acuta_HIv2___RNAseq.g26503.t1;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g28641.t1;Pocillopora_acuta_HIv2___RNAseq.g3016.t1;Pocillopora_acuta_HIv2___RNAseq.g7498.t1;Pocillopora_acuta_HIv2___TS.g19253.t1;Pocillopora_acuta_HIv2___TS.g3401.t1;Pocillopora_acuta_HIv2___TS.g4466.t2;Pocillopora_acuta_HIv2___TS.g6241.t1e;Pocillopora_acuta_HIv2___TS.g6681.t1;Pocillopora_acuta_HIv2___TS.g6682.t1;Pocillopora_acuta_HIv2___TS.g7609.t1b","Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase);CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1);L-threonine ammonia-lyase (EC 4.3.1.19) (L-serine ammonia-lyase) (EC 4.3.1.17) (Threonine dehydratase);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.53);Acireductone dioxygenase (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD') (Fe-ARD) (EC 1.13.11.54) (Acireductone dioxygenase (Ni(2+)-requiring)) (ARD) (Ni-ARD) (EC 1.13.11.53);Probable pyridoxal 5'-phosphate synthase subunit PDX2 (AtPDX2) (EC 4.3.3.6) (Protein EMBRYO DEFECTIVE 2407) (Pyridoxal 5'-phosphate synthase glutaminase subunit) (EC 3.5.1.2);Ornithine decarboxylase (ODC) (EC 4.1.1.17);3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31);Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);Protein TabA;Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I);Branched-chain-amino-acid aminotransferase (EC 2.6.1.42);Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)];Asparagine synthetase domain-containing protein 1;Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase);Glutamate dehydrogenase (GDH) (EC 1.4.1.3) (NAD(P)H-utilizing glutamate dehydrogenase);Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2);Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2);Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (O-phosphoserine phosphohydrolase)","2.013% (3/149)",0.8979354,0.05,NA,NA,"Cluster 11: biological_process"
"103","11",5.86,"GO:0141091","transforming growth factor beta receptor superfamily signaling pathway",NA,"5.185% (7/135)",0.8885541,0.05,NA,NA,"8.148% (11/135)",0.007617593,2.12,"Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.7335_t;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g15163.t1;Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g23673.t1","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1);Fibrillin-2 [Cleaved into: Placensin];Noggin-2;Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Signal peptide, CUB and EGF-like domain-containing protein 3","Cluster 11: biological_process"
"104","11",7.69,"GO:0051693","actin filament capping","The binding of a protein or protein complex to the end of an actin filament, thus preventing the addition, exchange or removal of further actin subunits.","25% (7/28)",0.003801781,2.42,"Pocillopora_acuta_HIv2___RNAseq.g11345.t1;Pocillopora_acuta_HIv2___RNAseq.g11810.t1;Pocillopora_acuta_HIv2___RNAseq.g3051.t1;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___RNAseq.g3142.t1a;Pocillopora_acuta_HIv2___RNAseq.g3840.t1;Pocillopora_acuta_HIv2___TS.g18947.t1","Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod);Spectrin beta chain, erythrocytic (Beta-I spectrin);Villin-1;Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Myotrophin;Advillin (p92);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)","0% (0/28)",1,0,NA,NA,"Cluster 11: biological_process"
"105","11",9.11,"GO:0070208","protein heterotrimerization","The formation of a protein heterotrimer, a macromolecular structure consisting of three noncovalently associated subunits, of which not all are identical.","0% (0/7)",1,0,NA,NA,"71.429% (5/7)",1.005146e-06,6,"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1","Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Cluster 11: biological_process"
"106","11",5.94,"GO:0006874","intracellular calcium ion homeostasis","A homeostatic process involved in the maintenance of a steady state level of calcium ions within a cell.","14.286% (18/126)",0.005880905,2.23,"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.g10777.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g18121.t1;Pocillopora_acuta_HIv2___RNAseq.g1838.t1;Pocillopora_acuta_HIv2___RNAseq.g19392.t1;Pocillopora_acuta_HIv2___RNAseq.g19452.t1;Pocillopora_acuta_HIv2___RNAseq.g24761.t1;Pocillopora_acuta_HIv2___RNAseq.g26672.t1;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g28270.t1;Pocillopora_acuta_HIv2___RNAseq.g4919.t1;Pocillopora_acuta_HIv2___RNAseq.g5755.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g8093.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___TS.g14552.t1","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);MICOS complex subunit Mic60 (Mitochondrial inner membrane protein) (Mitofilin);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2);m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1);1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2);Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2);Annexin A6 (Annexin VI) (Annexin-6);Neuronal acetylcholine receptor subunit alpha-7;Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Cadherin-23 (Otocadherin)","3.175% (4/126)",0.6474358,0.19,NA,NA,"Cluster 11: biological_process"
"107","11",8.57,"GO:0061484","hematopoietic stem cell homeostasis","Any biological process involved in the maintenance of the steady-state number of hematopoietic stem cells within a population of cells.","41.667% (5/12)",0.001185911,2.93,"Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g16957.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___TS.g1768.t1","Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Transcription factor SOX-4;Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","0% (0/12)",1,0,NA,NA,"Cluster 11: biological_process"
"108","11",7.97,"GO:0045792","negative regulation of cell size","Any process that reduces cell size.","4.545% (1/22)",0.820329,0.09,NA,NA,"18.182% (4/22)",0.006516369,2.19,"Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___TS.g5308.t2","Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Cluster 11: biological_process"
"109","12",9.27,"GO:0060232","delamination","The process of negative regulation of cell adhesion that results in a cell or sheet of cells splitting off from an existing epithelial sheet.","60% (3/5)",0.003742425,2.43,"Pocillopora_acuta_HIv2___RNAseq.g14615.t1;Pocillopora_acuta_HIv2___RNAseq.g7833.t1;Pocillopora_acuta_HIv2___TS.g27807.t1","Microtubule organization protein AKNA (AT-hook-containing transcription factor);N6-adenosine-methyltransferase catalytic subunit (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N6-adenosine-methyltransferase 70 kDa subunit) (MT-A70);Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12) (ATP-binding cassette 12)","20% (1/5)",0.1630389,0.79,NA,NA,"Cluster 12: regulation of cell adhesion"
"110","12",6.38,"GO:0007162","negative regulation of cell adhesion","Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion.","15.217% (14/92)",0.05842002,1.23,NA,NA,"11.957% (11/92)",0.0003453446,3.46,"Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g5896.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g11002.t4","Tissue inhibitor of metalloproteinase;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Probable N-acetyltransferase camello (EC 2.3.1.-) (Xcml);Protein jagged-1 (Jagged1) (CD antigen CD339);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Cluster 12: regulation of cell adhesion"
"111","12",9.45,"GO:1903385","regulation of homophilic cell adhesion",NA,"80% (4/5)",0.0001474401,3.83,"Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___TS.g1768.t1","Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","0% (0/5)",1,0,NA,NA,"Cluster 12: regulation of cell adhesion"
"112","12",6.53,"GO:0010810","regulation of cell-substrate adhesion","Any process that modulates the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.","2.41% (2/83)",0.9882648,0.01,NA,NA,"9.639% (8/83)",0.008288626,2.08,"Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g28109.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1","Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Fibulin-2 (FIBL-2);Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339)","Cluster 12: regulation of cell adhesion"
"113","13",6.3,"GO:0007160","cell-matrix adhesion","The binding of a cell to the extracellular matrix via adhesion molecules.","10.68% (11/103)",0.148111,0.83,NA,NA,"8.738% (9/103)",0.009829966,2.01,"Pocillopora_acuta_HIv2___RNAseq.g11876.t1;Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g13823.t1;Pocillopora_acuta_HIv2___RNAseq.g25351.t1;Pocillopora_acuta_HIv2___RNAseq.g28502.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g10825.t1","Mucin-like protein;Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Mucin-like protein;Mammalian ependymin-related protein 1 (MERP-1);Mucin-like protein;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module)","Cluster 13: cell adhesion"
"114","13",4.14,"GO:0007155","cell adhesion","The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.","10.272% (68/662)",0.03423333,1.47,NA,NA,"10.423% (69/662)",0.003718063,2.43,"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.6832_t;Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g1119.t1;Pocillopora_acuta_HIv2___RNAseq.g11876.t1;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g13823.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g14375.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g18385.t1;Pocillopora_acuta_HIv2___RNAseq.g19085.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g25351.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g25761.t1;Pocillopora_acuta_HIv2___RNAseq.g27031.t1;Pocillopora_acuta_HIv2___RNAseq.g28109.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28502.t1;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g29795.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___RNAseq.g3939.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g5896.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g9049.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g10825.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12860.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g24030.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g5308.t2;Pocillopora_acuta_HIv2___TS.g8258.t1;Pocillopora_acuta_HIv2___TS.g8259.t1b","Hemicentin-1 (Fibulin-6) (FIBL-6);Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B);Protocadherin Fat 3 (FAT tumor suppressor homolog 3);Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Collagen alpha-6(VI) chain;Mucin-like protein;Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Tissue inhibitor of metalloproteinase;Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Mucin-like protein;Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-4(VI) chain;Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains);Halomucin;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Hemicentin-2;Hemicentin-2;Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Mammalian ependymin-related protein 1 (MERP-1);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Collagen alpha-6(VI) chain;Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2);Fibulin-2 (FIBL-2);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Mucin-like protein;Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Roundabout homolog 2;Zonadhesin;Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Spondin-1 (F-spondin);Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Hemicentin-1 (Fibulin-6) (FIBL-6);Probable N-acetyltransferase camello (EC 2.3.1.-) (Xcml);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339);Protein turtle homolog B (Immunoglobulin superfamily member 9B);Hemicentin-1 (Fibulin-6) (FIBL-6);Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Collagen alpha-1(VI) chain;Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12);Hemicentin-2;Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Hemicentin-2;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)","Cluster 13: cell adhesion"
"115","13",8.23,"GO:0016339","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules","The attachment of one cell to another cell via adhesion molecules that require the presence of calcium for the interaction.","5.882% (1/17)",0.7344949,0.13,NA,NA,"29.412% (5/17)",0.0002216604,3.65,"Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g5308.t2","Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Cluster 13: cell adhesion"
"116","13",6.32,"GO:0007156","homophilic cell adhesion via plasma membrane adhesion molecules","The attachment of a plasma membrane adhesion molecule in one cell to an identical molecule in an adjacent cell.","15.789% (18/114)",0.03153152,1.5,NA,NA,"20.175% (23/114)",6.027593e-12,11.22,"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___RNAseq.g19085.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g5308.t2;Pocillopora_acuta_HIv2___TS.g8258.t1;Pocillopora_acuta_HIv2___TS.g8259.t1b","Hemicentin-1 (Fibulin-6) (FIBL-6);Protocadherin Fat 3 (FAT tumor suppressor homolog 3);Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Hemicentin-1 (Fibulin-6) (FIBL-6);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Halomucin;Hemicentin-2;Hemicentin-2;Roundabout homolog 2;Roundabout homolog 2;Hemicentin-1 (Fibulin-6) (FIBL-6);Roundabout homolog 1;Protein turtle homolog B (Immunoglobulin superfamily member 9B);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Hemicentin-2;Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Hemicentin-2;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)","Cluster 13: cell adhesion"
"117","13",7.39,"GO:0007157","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules","The attachment of an adhesion molecule in one cell to a nonidentical adhesion molecule in an adjacent cell.","10.256% (4/39)",0.3349231,0.48,NA,NA,"30.769% (12/39)",4.576971e-09,8.34,"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1","Hemicentin-1 (Fibulin-6) (FIBL-6);Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Hemicentin-1 (Fibulin-6) (FIBL-6);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Hemicentin-1 (Fibulin-6) (FIBL-6);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","Cluster 13: cell adhesion"
"118","14",6.42,"GO:0016079","synaptic vesicle exocytosis","Fusion of intracellular membrane-bounded vesicles with the pre-synaptic membrane of the neuronal cell resulting in release of neurotransmitter into the synaptic cleft.","20.69% (12/58)",0.001036913,2.98,"Pocillopora_acuta_HIv2___RNAseq.g12223.t1;Pocillopora_acuta_HIv2___RNAseq.g13403.t1;Pocillopora_acuta_HIv2___RNAseq.g26700.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28815.t1;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g4031.t1c;Pocillopora_acuta_HIv2___RNAseq.g8004.t1;Pocillopora_acuta_HIv2___TS.g18947.t1;Pocillopora_acuta_HIv2___TS.g28908.t1;Pocillopora_acuta_HIv2___TS.g3024.t4","Ras-related protein Rab-3;Synaptotagmin-9 (Synaptotagmin IX) (SytIX);Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI);Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Complexin-1;Protein unc-13 homolog C (Munc13-3)","3.448% (2/58)",0.6071739,0.22,NA,NA,"Cluster 14: secretion by cell"
"119","14",8.57,"GO:0001956","positive regulation of neurotransmitter secretion","Any process that activates or increases the frequency, rate or extent of the regulated release of a neurotransmitter.","36.364% (4/11)",0.006750758,2.17,"Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g28815.t1;Pocillopora_acuta_HIv2___RNAseq.g4031.t1c;Pocillopora_acuta_HIv2___RNAseq.g8004.t1","Adenosine receptor A2a;Synaptotagmin-1 (Synaptotagmin I) (SytI);Synaptotagmin-1 (Synaptotagmin I) (SytI);Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein)","9.091% (1/11)",0.3240775,0.49,NA,NA,"Cluster 14: secretion by cell"
"120","14",8.01,"GO:0014059","regulation of dopamine secretion","Any process that modulates the frequency, rate or extent of the regulated release of dopamine.","28.571% (6/21)",0.003554689,2.45,"Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g28815.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g4031.t1c;Pocillopora_acuta_HIv2___RNAseq.g8004.t1","Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Synaptotagmin-1 (Synaptotagmin I) (SytI);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Synaptotagmin-1 (Synaptotagmin I) (SytI);Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein)","0% (0/21)",1,0,NA,NA,"Cluster 14: secretion by cell"
"121","14",6.81,"GO:0050796","regulation of insulin secretion","Any process that modulates the frequency, rate or extent of the regulated release of insulin.","16.667% (11/66)",0.009390146,2.03,"Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g16957.t1;Pocillopora_acuta_HIv2___RNAseq.g25689.t1;Pocillopora_acuta_HIv2___RNAseq.g25869.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___RNAseq.g993.t1;Pocillopora_acuta_HIv2___RNAseq.g994.t1;Pocillopora_acuta_HIv2___TS.g15672.t1;Pocillopora_acuta_HIv2___TS.g27807.t1","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Transcription factor SOX-4;Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor);DNA-binding protein RFX6 (Regulatory factor X 6);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34);Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34);Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7);Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12) (ATP-binding cassette 12)","1.515% (1/66)",0.9052983,0.04,NA,NA,"Cluster 14: secretion by cell"
"122","14",9.27,"GO:0014049","positive regulation of glutamate secretion","Any process that activates or increases the frequency, rate or extent of the controlled release of glutamate.","50% (3/6)",0.007068856,2.15,"Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g8004.t1","Adenosine receptor A2a;Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein)","0% (0/6)",1,0,NA,NA,"Cluster 14: secretion by cell"
"123","14",8.29,"GO:0045956","positive regulation of calcium ion-dependent exocytosis","Any process that activates or increases the frequency, rate or extent of calcium ion-dependent exocytosis.","33.333% (5/15)",0.003721266,2.43,"Pocillopora_acuta_HIv2___RNAseq.30415_t;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28815.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g4031.t1c","Synaptotagmin-10 (Synaptotagmin X) (SytX);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI)","6.667% (1/15)",0.4138734,0.38,NA,NA,"Cluster 14: secretion by cell"
"124","15",7.39,"GO:0051932","synaptic transmission, GABAergic","The vesicular release of gamma-aminobutyric acid (GABA). from a presynapse, across a chemical synapse, the subsequent activation of GABA receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.","23.684% (9/38)",0.001606486,2.79,"Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g13672.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g6468.t1;Pocillopora_acuta_HIv2___TS.g305.t1","Adenosine receptor A2a;Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Adenosine receptor A2a;Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","5.263% (2/38)",0.3855172,0.41,NA,NA,"Cluster 15: cell-cell signaling"
"125","15",8.57,"GO:0150099","neuron-glial cell signaling",NA,"33.333% (4/12)",0.009533181,2.02,"Pocillopora_acuta_HIv2___RNAseq.g17965.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___TS.g305.t1","Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","0% (0/12)",1,0,NA,NA,"Cluster 15: cell-cell signaling"
"126","15",8.57,"GO:0099545","trans-synaptic signaling by trans-synaptic complex","Cell-cell signaling between presynapse and postsynapse mediated by a trans-synaptic protein complex.","0% (0/12)",1,0,NA,NA,"25% (3/12)",0.007365383,2.13,"Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1","Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","Cluster 15: cell-cell signaling"
"127","15",9.45,"GO:1990926","short-term synaptic potentiation",NA,"60% (3/5)",0.003742425,2.43,"Pocillopora_acuta_HIv2___RNAseq.g26700.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1","Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII)","0% (0/5)",1,0,NA,NA,"Cluster 15: cell-cell signaling"
"128","15",8.86,"GO:0060080","inhibitory postsynaptic potential","A process that causes a temporary decrease in postsynaptic membrane potential due to the flow of negatively charged ions into the postsynaptic cell. The flow of ions that causes an IPSP is an inhibitory postsynaptic current (IPSC) and makes it more difficult for the neuron to fire an action potential.","55.556% (5/9)",0.0002282419,3.64,"Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g6468.t1","Adenosine receptor A2a;Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Adenosine receptor A2a","11.111% (1/9)",0.274162,0.56,NA,NA,"Cluster 15: cell-cell signaling"
"129","16",6.58,"GO:0062208","positive regulation of pattern recognition receptor signaling pathway","Any process that decreases the rate, frequency or extent of a pattern recognition receptor signaling pathway.","18.367% (9/49)",0.009675179,2.01,"Pocillopora_acuta_HIv2___RNAseq.g17047.t1;Pocillopora_acuta_HIv2___RNAseq.g18756.t2;Pocillopora_acuta_HIv2___RNAseq.g30624.t2b;Pocillopora_acuta_HIv2___RNAseq.g7625.t1;Pocillopora_acuta_HIv2___RNAseq.g7628.t1;Pocillopora_acuta_HIv2___RNAseq.g763.t1;Pocillopora_acuta_HIv2___RNAseq.g7881.t1;Pocillopora_acuta_HIv2___TS.g15668.t1;Pocillopora_acuta_HIv2___TS.g4312.t1","Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2);Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97);Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein);Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281);Toll-like receptor 6 (CD antigen CD286);Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22);Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60);Myeloid differentiation primary response protein MyD88;Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22)","0% (0/49)",1,0,NA,NA,"Cluster 16: regulation of biological process"
"130","16",7.73,"GO:0045747","positive regulation of Notch signaling pathway","Any process that activates or increases the frequency, rate or extent of the Notch signaling pathway.","7.143% (2/28)",0.631649,0.2,NA,NA,"21.429% (6/28)",0.000342573,3.47,"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g3509.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1","Roundabout homolog 2;E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26);Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339)","Cluster 16: regulation of biological process"
"131","16",4.19,"GO:0042127","regulation of cell population proliferation","Any process that modulates the frequency, rate or extent of cell proliferation.","8.07% (51/632)",0.3080911,0.51,NA,NA,"6.487% (41/632)",0.00070042,3.15,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g10557.t1;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g14750.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g25184.t1;Pocillopora_acuta_HIv2___RNAseq.g25186.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g26604.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g3509.t1;Pocillopora_acuta_HIv2___RNAseq.g3780.t1;Pocillopora_acuta_HIv2___RNAseq.g434.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g9049.t1;Pocillopora_acuta_HIv2___TS.7324_t;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g13017.t1;Pocillopora_acuta_HIv2___TS.g28528.t1b;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g568.t1","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Fibroblast growth factor receptor-like 1;Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Collagen triple helix repeat-containing protein 1;Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);TNF receptor-associated factor 5;TNF receptor-associated factor 5;Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1);Protein Wnt-7a;Protein Wnt-8a;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26);Protein kinase C-binding protein NELL1 (NEL-like protein 1);Frizzled-5 (Fz-5) (Xfz5);Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1);Homeobox protein koza (Homeodomain transcription factor koza);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Aryl hydrocarbon receptor (Ah receptor) (AhR);Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)","Cluster 16: regulation of biological process"
"132","16",5.76,"GO:0060070","canonical Wnt signaling pathway","A type of Wnt signaling pathway in which Wnt binding to its receptor on the surface of a target cell results in the by propagation of the molecular signals via beta-catenin, and end with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.","6.936% (12/173)",0.6536476,0.18,NA,NA,"9.249% (16/173)",0.0003583085,3.45,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.g17416.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g21032.t1;Pocillopora_acuta_HIv2___RNAseq.g2565.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g3088.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Glypican-5 [Cleaved into: Secreted glypican-5];Collagen triple helix repeat-containing protein 1;Protein naked cuticle homolog 2-like (Naked-2-like) (Protein naked cuticle homolog 2-B) (Naked-2B);Secreted frizzled-related protein 5 (sFRP-5);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Nephrocystin-3;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Protein Wnt-8b;Protein Wnt-8b","Cluster 16: regulation of biological process"
"133","16",8.49,"GO:0007214","gamma-aminobutyric acid signaling pathway","The series of molecular signals generated by the binding of gamma-aminobutyric acid (GABA, 4-aminobutyrate), an amino acid which acts as a neurotransmitter in some organisms, to its receptor on the surface of a target cell.","38.462% (5/13)",0.001809052,2.74,"Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___TS.g305.t1","Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","7.692% (1/13)",0.3705699,0.43,NA,NA,"Cluster 16: regulation of biological process"
"134","16",4.74,"GO:0007186","G protein-coupled receptor signaling pathway","The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane.","11.696% (40/342)",0.003131473,2.5,"Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.5883_t;Pocillopora_acuta_HIv2___RNAseq.g10339.t1;Pocillopora_acuta_HIv2___RNAseq.g1102.t1;Pocillopora_acuta_HIv2___RNAseq.g11214.t1;Pocillopora_acuta_HIv2___RNAseq.g11547.t1;Pocillopora_acuta_HIv2___RNAseq.g11548.t1;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g13056.t1;Pocillopora_acuta_HIv2___RNAseq.g14013.t1a;Pocillopora_acuta_HIv2___RNAseq.g14869.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g17965.t1;Pocillopora_acuta_HIv2___RNAseq.g19392.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g22296.t1;Pocillopora_acuta_HIv2___RNAseq.g2263.t1b;Pocillopora_acuta_HIv2___RNAseq.g22964.t1;Pocillopora_acuta_HIv2___RNAseq.g23414.t1;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g25689.t1;Pocillopora_acuta_HIv2___RNAseq.g27609.t1;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g28213.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g28742.t1;Pocillopora_acuta_HIv2___RNAseq.g30398.t1;Pocillopora_acuta_HIv2___RNAseq.g3723.t1;Pocillopora_acuta_HIv2___RNAseq.g3854.t1;Pocillopora_acuta_HIv2___RNAseq.g6366.t1;Pocillopora_acuta_HIv2___RNAseq.g6379.t1;Pocillopora_acuta_HIv2___RNAseq.g6468.t1;Pocillopora_acuta_HIv2___RNAseq.g8004.t1;Pocillopora_acuta_HIv2___RNAseq.g8217.t1;Pocillopora_acuta_HIv2___RNAseq.g8890.t1;Pocillopora_acuta_HIv2___RNAseq.g9811.t1;Pocillopora_acuta_HIv2___TS.g1253.t1;Pocillopora_acuta_HIv2___TS.g2952.t1;Pocillopora_acuta_HIv2___TS.g305.t1","Metabotropic glutamate receptor 3 (mGluR3);Calcium/calmodulin-dependent protein kinase type II subunit alpha (CaM kinase II subunit alpha) (CaMK-II subunit alpha) (EC 2.7.11.17);Adenosine receptor A2b;Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor);Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Adenosine receptor A2a;Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Dopamine receptor 4;Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR);Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor);1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);BTB/POZ domain-containing protein KCTD16;Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71);Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25);5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor);cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE);Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);QRFP-like peptide receptor;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);LWamide neuropeptides [Cleaved into: LWamide I; LWamide II; LWS];Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133);Tachykinin-like peptides receptor 86C (NKD);Adhesion G protein-coupled receptor L4;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133);Adenosine receptor A2a;Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein);LWamide neuropeptides [Cleaved into: LWamide I; Metamorphosin A (MMA) (LWamide II); LWamide III; LWamide IV; LWamide V; LWamide VI; LWamide VII; LWamide VIII; LWamide IX];Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor);Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor);Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1);Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","4.678% (16/342)",0.1445364,0.84,NA,NA,"Cluster 16: regulation of biological process"
"135","17",6.36,"GO:0017148","negative regulation of translation","Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA.","15.476% (13/84)",0.009327027,2.03,"Pocillopora_acuta_HIv2___RNAseq.g10158.t1;Pocillopora_acuta_HIv2___RNAseq.g1103.t1;Pocillopora_acuta_HIv2___RNAseq.g16905.t1;Pocillopora_acuta_HIv2___RNAseq.g1800.t1;Pocillopora_acuta_HIv2___RNAseq.g18756.t2;Pocillopora_acuta_HIv2___RNAseq.g219.t1;Pocillopora_acuta_HIv2___RNAseq.g24051.t1;Pocillopora_acuta_HIv2___RNAseq.g24787.t1;Pocillopora_acuta_HIv2___RNAseq.g24800.t1;Pocillopora_acuta_HIv2___RNAseq.g28169.t1;Pocillopora_acuta_HIv2___RNAseq.g4938.t1;Pocillopora_acuta_HIv2___RNAseq.g763.t1;Pocillopora_acuta_HIv2___TS.g4312.t1","Cytoplasmic polyadenylation element-binding protein 2 (CPE-BP2) (CPE-binding protein 2) (mCPEB-2);Mitochondrial assembly of ribosomal large subunit protein 1;E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97);Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2);Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2);E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22);Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22)","0% (0/84)",1,0,NA,NA,"Cluster 17: metabolic process"
"136","17",9.27,"GO:0051045","negative regulation of membrane protein ectodomain proteolysis","Any process that stops, prevents, or reduces the frequency, rate or extent of membrane protein ectodomain proteolysis.","0% (0/6)",1,0,NA,NA,"50% (3/6)",0.000783016,3.11,"Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g30027.t1","Tissue inhibitor of metalloproteinase;Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4)","Cluster 17: metabolic process"
"137","17",9.11,"GO:0050427","3'-phosphoadenosine 5'-phosphosulfate metabolic process","The chemical reactions and pathways involving 3'-phosphoadenosine 5'-phosphosulfate, a naturally occurring mixed anhydride. It is an intermediate in the formation of a variety of sulfo compounds in biological systems.","85.714% (6/7)",1.141908e-06,5.94,"Pocillopora_acuta_HIv2___RNAseq.10969_t;Pocillopora_acuta_HIv2___RNAseq.g12481.t1;Pocillopora_acuta_HIv2___RNAseq.g21538.t1;Pocillopora_acuta_HIv2___RNAseq.g25759.t1;Pocillopora_acuta_HIv2___RNAseq.g9089.t1;Pocillopora_acuta_HIv2___RNAseq.g9093.t1","Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase);Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1);Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase);Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPS synthetase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)];Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1);Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2)","0% (0/7)",1,0,NA,NA,"Cluster 17: metabolic process"
"138","17",8.11,"GO:0009208","pyrimidine ribonucleoside triphosphate metabolic process","The chemical reactions and pathways involving pyrimidine ribonucleoside triphosphate, a compound consisting of a pyrimidine base linked to a ribose sugar esterified with triphosphate on the sugar.","33.333% (4/12)",0.009533181,2.02,"Pocillopora_acuta_HIv2___RNAseq.g11840.t1;Pocillopora_acuta_HIv2___RNAseq.g21884.t1;Pocillopora_acuta_HIv2___RNAseq.g3911.t1;Pocillopora_acuta_HIv2___TS.g19040.t1","CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1);Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.15) (EC 3.6.1.6) (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase) (EC 3.6.1.42);Nucleoside diphosphate kinase homolog 5 (3'-5' exonuclease NME5) (EC 3.1.-.-);GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (Adenylate kinase 3 alpha-like 1) (Adenylate kinase isozyme 3)","0% (0/12)",1,0,NA,NA,"Cluster 17: metabolic process"
"139","17",8.11,"GO:0016114","terpenoid biosynthetic process","The chemical reactions and pathways resulting in the formation of terpenoids, any member of a class of compounds characterized by an isoprenoid chemical structure.","33.333% (4/12)",0.009533181,2.02,"Pocillopora_acuta_HIv2___RNAseq.g28425.t1;Pocillopora_acuta_HIv2___RNAseq.g610.t1;Pocillopora_acuta_HIv2___RNAseq.g9824.t1;Pocillopora_acuta_HIv2___RNAseq.g9825.t1","Protein arginine N-methyltransferase 3 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3);Serine/threonine-protein kinase CTR1 (EC 2.7.11.1) (Protein CONSTITUTIVE TRIPLE RESPONSE1);Methyltransferase flvH (EC 2.1.1.-) (Flavunoidine biosynthesis cluster protein H);Methyltransferase flvH (EC 2.1.1.-) (Flavunoidine biosynthesis cluster protein H)","0% (0/12)",1,0,NA,NA,"Cluster 17: metabolic process"
"140","17",6.43,"GO:1901607","alpha-amino acid biosynthetic process",NA,"17.105% (13/76)",0.003948213,2.4,"Pocillopora_acuta_HIv2___RNAseq.g10854.t2;Pocillopora_acuta_HIv2___RNAseq.g12417.t1;Pocillopora_acuta_HIv2___RNAseq.g1504.t1;Pocillopora_acuta_HIv2___RNAseq.g16699.t1;Pocillopora_acuta_HIv2___RNAseq.g19367.t1;Pocillopora_acuta_HIv2___RNAseq.g23634.t1;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g28641.t1;Pocillopora_acuta_HIv2___RNAseq.g7498.t1;Pocillopora_acuta_HIv2___TS.g19253.t1;Pocillopora_acuta_HIv2___TS.g3401.t1;Pocillopora_acuta_HIv2___TS.g6241.t1e;Pocillopora_acuta_HIv2___TS.g7609.t1b","Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase);Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2);L-threonine ammonia-lyase (EC 4.3.1.19) (L-serine ammonia-lyase) (EC 4.3.1.17) (Threonine dehydratase);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.53);Acireductone dioxygenase (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD') (Fe-ARD) (EC 1.13.11.54) (Acireductone dioxygenase (Ni(2+)-requiring)) (ARD) (Ni-ARD) (EC 1.13.11.53);Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);Protein TabA;Branched-chain-amino-acid aminotransferase (EC 2.6.1.42);Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)];Asparagine synthetase domain-containing protein 1;Glutamate dehydrogenase (GDH) (EC 1.4.1.3) (NAD(P)H-utilizing glutamate dehydrogenase);Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (O-phosphoserine phosphohydrolase)","1.316% (1/76)",0.9338356,0.03,NA,NA,"Cluster 17: metabolic process"
"141","17",9.27,"GO:0046314","phosphocreatine biosynthetic process","The chemical reactions and pathways resulting in the formation of phosphocreatine, a phosphagen of creatine which is synthesized and broken down by creatine phosphokinase.","66.667% (4/6)",0.0004159939,3.38,"Pocillopora_acuta_HIv2___RNAseq.g15574.t1;Pocillopora_acuta_HIv2___RNAseq.g15577.t1;Pocillopora_acuta_HIv2___RNAseq.g15584.t1;Pocillopora_acuta_HIv2___RNAseq.g2258.t1","Creatine kinase, testis isozyme (EC 2.7.3.2);Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK);Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK);Arginine kinase (AK) (EC 2.7.3.3)","0% (0/6)",1,0,NA,NA,"Cluster 17: metabolic process"
"142","18",8.86,"GO:0051923","sulfation","The addition of a sulfate group to a molecule.","44.444% (4/9)",0.002909709,2.54,"Pocillopora_acuta_HIv2___RNAseq.10969_t;Pocillopora_acuta_HIv2___RNAseq.g21538.t1;Pocillopora_acuta_HIv2___RNAseq.g9090.t1;Pocillopora_acuta_HIv2___RNAseq.g9093.t1","Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase);Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase);Sulfotransferase 1C2A (ST1C2A) (rSULT1C2A) (EC 2.8.2.1) (Sulfotransferase K2);Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2)","0% (0/9)",1,0,NA,NA,"Cluster 18: metabolic process"
"143","18",7.42,"GO:0044550","secondary metabolite biosynthetic process","The chemical reactions and pathways resulting in the formation of secondary metabolites, the compounds that are not necessarily required for growth and maintenance of cells, and are often unique to a taxon.","17.391% (4/23)",0.08890012,1.05,NA,NA,"17.391% (4/23)",0.007674739,2.11,"Pocillopora_acuta_HIv2___RNAseq.g13784.t1;Pocillopora_acuta_HIv2___RNAseq.g22361.t1;Pocillopora_acuta_HIv2___RNAseq.g4679.t1;Pocillopora_acuta_HIv2___TS.g12260.t1","Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase);Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)];Ras-related protein Rab-38 (Melanoma antigen NY-MEL-1);Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)","Cluster 18: metabolic process"
"144","18",7.13,"GO:0032963","collagen metabolic process","The chemical reactions and pathways involving collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).","1.961% (1/51)",0.9814224,0.01,NA,NA,"21.569% (11/51)",0.0005718667,3.24,"Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g28528.t1a;Pocillopora_acuta_HIv2___TS.g5338.t1","Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)","Cluster 18: metabolic process"
"145","18",8.06,"GO:0030574","collagen catabolic process","The proteolytic chemical reactions and pathways resulting in the breakdown of collagen in the extracellular matrix, usually carried out by proteases secreted by nearby cells.","5% (1/20)",0.7899479,0.1,NA,NA,"25% (5/20)",0.0005093552,3.29,"Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___TS.g28528.t1a;Pocillopora_acuta_HIv2___TS.g5338.t1","Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)","Cluster 18: metabolic process"
"146","18",8.66,"GO:0006030","chitin metabolic process","The chemical reactions and pathways involving chitin, a linear polysaccharide consisting of beta-(1->4)-linked N-acetyl-D-glucosamine residues.","9.091% (1/11)",0.5759044,0.24,NA,NA,"45.455% (5/11)",0.003513907,2.45,"Pocillopora_acuta_HIv2___RNAseq.g12372.t1;Pocillopora_acuta_HIv2___RNAseq.g12376.t1;Pocillopora_acuta_HIv2___RNAseq.g25270.t1;Pocillopora_acuta_HIv2___RNAseq.g28575.t1a;Pocillopora_acuta_HIv2___RNAseq.g28577.t1","Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)","Cluster 18: metabolic process"
"147","18",8.98,"GO:0006032","chitin catabolic process","The chemical reactions and pathways resulting in the breakdown of chitin, a linear polysaccharide consisting of beta-(1->4)-linked N-acetyl-D-glucosamine residues.","12.5% (1/8)",0.4640687,0.33,NA,NA,"37.5% (3/8)",0.002080615,2.68,"Pocillopora_acuta_HIv2___RNAseq.g12372.t1;Pocillopora_acuta_HIv2___RNAseq.g12376.t1;Pocillopora_acuta_HIv2___RNAseq.g25270.t1","Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41)","Cluster 18: metabolic process"
"148","18",9.45,"GO:0006068","ethanol catabolic process","The chemical reactions and pathways resulting in the breakdown of ethanol, CH3-CH2-OH, a colorless, water-miscible, flammable liquid produced by alcoholic fermentation.","60% (3/5)",0.003742425,2.43,"Pocillopora_acuta_HIv2___RNAseq.10969_t;Pocillopora_acuta_HIv2___RNAseq.g21538.t1;Pocillopora_acuta_HIv2___RNAseq.g9093.t1","Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase);Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase);Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2)","0% (0/5)",1,0,NA,NA,"Cluster 18: metabolic process"
"149","18",7.69,"GO:0031638","zymogen activation","The proteolytic processing of an inactive enzyme to an active form.","6.897% (2/29)",0.6508682,0.19,NA,NA,"20.69% (6/29)",0.0004193844,3.38,"Pocillopora_acuta_HIv2___RNAseq.21012_t;Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g30322.t1;Pocillopora_acuta_HIv2___RNAseq.g9381.t1","Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","Cluster 18: metabolic process"
"150","18",6.37,"GO:0009308","amine metabolic process","The chemical reactions and pathways involving any organic compound that is weakly basic in character and contains an amino or a substituted amino group. Amines are called primary, secondary, or tertiary according to whether one, two, or three carbon atoms are attached to the nitrogen atom.","17.188% (11/64)",0.007446749,2.13,"Pocillopora_acuta_HIv2___RNAseq.10969_t;Pocillopora_acuta_HIv2___RNAseq.g11785.t1;Pocillopora_acuta_HIv2___RNAseq.g15141.t1;Pocillopora_acuta_HIv2___RNAseq.g20712.t1;Pocillopora_acuta_HIv2___RNAseq.g21538.t1;Pocillopora_acuta_HIv2___RNAseq.g21957.t1;Pocillopora_acuta_HIv2___RNAseq.g22120.t1;Pocillopora_acuta_HIv2___RNAseq.g26474.t1a;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g28398.t1;Pocillopora_acuta_HIv2___TS.g805.t1a","Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase);S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain];Cytokinin riboside 5'-monophosphate phosphoribohydrolase LOG3 (EC 3.2.2.n1) (Protein LONELY GUY 3);DBH-like monooxygenase protein 2 homolog (EC 1.14.17.-);Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase);DBH-like monooxygenase protein 1 (EC 1.14.17.-) (Monooxygenase X);DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X);Ornithine decarboxylase (ODC) (EC 4.1.1.17);Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein);Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase)","4.688% (3/64)",0.3886429,0.41,NA,NA,"Cluster 18: metabolic process"
"151","18",9.11,"GO:0009812","flavonoid metabolic process","The chemical reactions and pathways involving flavonoids, a group of water-soluble phenolic derivatives containing a flavan skeleton including flavones, flavonols and flavanoids, and anthocyanins.","71.429% (5/7)",4.321628e-05,4.36,"Pocillopora_acuta_HIv2___RNAseq.10969_t;Pocillopora_acuta_HIv2___RNAseq.g12481.t1;Pocillopora_acuta_HIv2___RNAseq.g21538.t1;Pocillopora_acuta_HIv2___RNAseq.g9089.t1;Pocillopora_acuta_HIv2___RNAseq.g9093.t1","Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase);Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1);Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase);Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1);Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2)","0% (0/7)",1,0,NA,NA,"Cluster 18: metabolic process"
"152","19",9.27,"GO:0014832","urinary bladder smooth muscle contraction","A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. This process occurs in the urinary bladder. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. The urinary bladder is a musculomembranous sac along the urinary tract.","50% (3/6)",0.007068856,2.15,"Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g6094.t2;Pocillopora_acuta_HIv2___RNAseq.g9466.t1","Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor)","0% (0/6)",1,0,NA,NA,"Cluster 19: multicellular organismal process"
"153","19",8.06,"GO:0050802","circadian sleep/wake cycle, sleep","The part of the circadian sleep/wake cycle where the organism is asleep.","31.579% (6/19)",0.002022309,2.69,"Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g16948.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1","Adenosine receptor A2a;Neurocalcin homolog (DrosNCa);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2)","0% (0/19)",1,0,NA,NA,"Cluster 19: multicellular organismal process"
"154","19",8.29,"GO:0097150","neuronal stem cell population maintenance","Any process in by an organism or tissue maintains a population of neuronal stem cells.","6.25% (1/16)",0.7129348,0.15,NA,NA,"25% (4/16)",0.001912828,2.72,"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g11002.t4","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Cluster 19: multicellular organismal process"
"155","19",8.35,"GO:0097242","amyloid-beta clearance","The process in which amyloid-beta is removed from extracellular brain regions by mechanisms involving cell surface receptors.","7.692% (1/13)",0.637188,0.2,NA,NA,"23.077% (3/13)",0.009330015,2.03,"Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1","Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","Cluster 19: multicellular organismal process"
"156","19",6.73,"GO:0050817","coagulation","The process in which a fluid solution, or part of it, changes into a solid or semisolid mass.","9.836% (6/61)",0.3064119,0.51,NA,NA,"11.475% (7/61)",0.005167809,2.29,"Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g22559.t1;Pocillopora_acuta_HIv2___RNAseq.g28195.t1;Pocillopora_acuta_HIv2___RNAseq.g30215.t1;Pocillopora_acuta_HIv2___RNAseq.g4785.t1;Pocillopora_acuta_HIv2___RNAseq.g4791.t1","Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Serine protease inhibitor dipetalogastin (Dipetalin);Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Coagulation factor VIII (Procoagulant component);Coagulation factor VIII (Procoagulant component)","Cluster 19: multicellular organismal process"
"157","20",6.81,"GO:0007613","memory","The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task).","10.294% (7/68)",0.2464151,0.61,NA,NA,"10.294% (7/68)",0.009336174,2.03,"Pocillopora_acuta_HIv2___RNAseq.g14748.t1;Pocillopora_acuta_HIv2___RNAseq.g21562.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28252.t1;Pocillopora_acuta_HIv2___RNAseq.g9085.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g23391.t1","Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) (Calspermin);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","Cluster 20: nervous system process"
"158","20",9.27,"GO:1990708","conditioned place preference",NA,"0% (0/6)",1,0,NA,NA,"50% (3/6)",0.000783016,3.11,"Pocillopora_acuta_HIv2___RNAseq.g21562.t1;Pocillopora_acuta_HIv2___RNAseq.g9085.t1;Pocillopora_acuta_HIv2___TS.g23391.t1","CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","Cluster 20: nervous system process"
"159","20",6.88,"GO:0031644","regulation of nervous system process","Any process that modulates the frequency, rate or extent of a neurophysiological process, an organ system process carried out by any of the organs or tissues of the nervous system.","5.556% (3/54)",0.7811182,0.11,NA,NA,"12.963% (7/54)",0.002582555,2.59,"Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g7509.t2;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g8670.t1;Pocillopora_acuta_HIv2___TS.g7062.t1","Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Protein Wnt-7a;Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal];Protein turtle homolog B (Immunoglobulin superfamily member 9B);Riboflavin-binding protein (RBP) [Cleaved into: Riboflavin-binding protein, plasma form; Riboflavin-binding protein, yolk major form; Riboflavin-binding protein, yolk minor form];Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","Cluster 20: nervous system process"
"160","20",8.66,"GO:0050955","thermoception","The series of events required for an organism to receive a temperature stimulus, convert it to a molecular signal, and recognize and characterize the signal. Thermoception in larger animals is mainly done in the skin; mammals have at least two types of sensor, for detecting heat (temperatures above body temperature) and cold (temperatures below body temperature).","40% (4/10)",0.004563944,2.34,"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.g5711.t2;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___TS.g14960.t2","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6)","0% (0/10)",1,0,NA,NA,"Cluster 20: nervous system process"
"161","20",6.9,"GO:0050906","detection of stimulus involved in sensory perception","The series of events involved in sensory perception in which a sensory stimulus is received and converted into a molecular signal.","22.5% (9/40)",0.002354769,2.63,"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g5711.t2;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___TS.g14960.t2;Pocillopora_acuta_HIv2___TS.g15134.t1;Pocillopora_acuta_HIv2___TS.g21857.t1;Pocillopora_acuta_HIv2___TS.g4109.t3;Pocillopora_acuta_HIv2___TS.g9513.t1","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);Mechanosensory protein 2;Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3);Pejvakin (Autosomal recessive deafness type 59 protein);Carcinine transporter","2.5% (1/40)",0.759852,0.12,NA,NA,"Cluster 20: nervous system process"
"162","20",5.24,"GO:0007600","sensory perception","The series of events required for an organism to receive a sensory stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.","16.25% (39/240)",0.007193843,2.14,"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.26564_t;Pocillopora_acuta_HIv2___RNAseq.30415_t;Pocillopora_acuta_HIv2___RNAseq.665_t;Pocillopora_acuta_HIv2___RNAseq.g11580.t1;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g13970.t2;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g20846.t1;Pocillopora_acuta_HIv2___RNAseq.g21265.t1;Pocillopora_acuta_HIv2___RNAseq.g23181.t1;Pocillopora_acuta_HIv2___RNAseq.g243.t1;Pocillopora_acuta_HIv2___RNAseq.g25708.t1;Pocillopora_acuta_HIv2___RNAseq.g26058.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g29670.t2;Pocillopora_acuta_HIv2___RNAseq.g3166.t1;Pocillopora_acuta_HIv2___RNAseq.g5711.t2;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1;Pocillopora_acuta_HIv2___RNAseq.g7452.t1;Pocillopora_acuta_HIv2___RNAseq.g7454.t2;Pocillopora_acuta_HIv2___RNAseq.g8093.t1;Pocillopora_acuta_HIv2___RNAseq.g8520.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___TS.g14552.t1;Pocillopora_acuta_HIv2___TS.g14960.t2;Pocillopora_acuta_HIv2___TS.g15134.t1;Pocillopora_acuta_HIv2___TS.g21857.t1;Pocillopora_acuta_HIv2___TS.g23175.t1;Pocillopora_acuta_HIv2___TS.g24807.t1;Pocillopora_acuta_HIv2___TS.g28111.t1;Pocillopora_acuta_HIv2___TS.g4109.t3;Pocillopora_acuta_HIv2___TS.g9513.t1","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);Metabotropic glutamate receptor 3 (mGluR3);Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2);Synaptotagmin-10 (Synaptotagmin X) (SytX);POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C);Hemicentin-1 (Fibulin-6) (FIBL-6);Adenosine receptor A2a;Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase);Myosin-VIIa (Protein crinkled);Nephrocystin-3;Lipoxygenase homology domain-containing protein 1;Rhodopsin, GQ-coupled (GQ-rhodopsin);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3);Rhodopsin;WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Nephrocystin-3;Nephrocystin-3;Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7);Hemicentin-1 (Fibulin-6) (FIBL-6);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Cadherin-23 (Otocadherin);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);Mechanosensory protein 2;Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);F-box only protein 11;Pejvakin (Autosomal recessive deafness type 59 protein);Carcinine transporter","3.75% (9/240)",0.4634434,0.33,NA,NA,"Cluster 20: nervous system process"
"163","20",6.55,"GO:0007605","sensory perception of sound","The series of events required for an organism to receive an auditory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Sonic stimuli are detected in the form of vibrations and are processed to form a sound.","16.092% (14/87)",0.005013811,2.3,"Pocillopora_acuta_HIv2___RNAseq.26564_t;Pocillopora_acuta_HIv2___RNAseq.665_t;Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g20846.t1;Pocillopora_acuta_HIv2___RNAseq.g23181.t1;Pocillopora_acuta_HIv2___RNAseq.g25708.t1;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1;Pocillopora_acuta_HIv2___RNAseq.g8093.t1;Pocillopora_acuta_HIv2___TS.g14552.t1;Pocillopora_acuta_HIv2___TS.g28111.t1;Pocillopora_acuta_HIv2___TS.g4109.t3","Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2);POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);Myosin-VIIa (Protein crinkled);Lipoxygenase homology domain-containing protein 1;Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7);Cadherin-23 (Otocadherin);F-box only protein 11;Pejvakin (Autosomal recessive deafness type 59 protein)","2.299% (2/87)",0.8135843,0.09,NA,NA,"Cluster 20: nervous system process"
"164","21",6.24,"GO:0071774","response to fibroblast growth factor","Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fibroblast growth factor stimulus.","14% (14/100)",0.01670912,1.78,NA,NA,"10% (10/100)",0.002532077,2.6,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g6737.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Protein Wnt-8a;ETS domain-containing protein Elk-1;Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","Cluster 21: response to stimulus"
"165","21",9.45,"GO:0071873","response to norepinephrine","Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a norepinephrine stimulus. Norepinephrine is a catecholamine that has the formula C8H11NO3; it acts as a hormone, and as a neurotransmitter in most of the sympathetic nervous system.","0% (0/5)",1,0,NA,NA,"100% (5/5)",5.073453e-08,7.29,"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1","Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Cluster 21: response to stimulus"
"166","21",9.45,"GO:0071799","cellular response to prostaglandin D stimulus","Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin D stimulus.","20% (1/5)",0.3227936,0.49,NA,NA,"60% (3/5)",0.0004019195,3.4,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","Cluster 21: response to stimulus"
"167","21",8.86,"GO:0097067","cellular response to thyroid hormone stimulus","A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.","0% (0/9)",1,0,NA,NA,"66.667% (6/9)",1.34246e-07,6.87,"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1","Collagen alpha-2(I) chain (Alpha-2 type I collagen);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Cluster 21: response to stimulus"
"168","21",8.57,"GO:0071305","cellular response to vitamin D","Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus.","16.667% (2/12)",0.2257181,0.65,NA,NA,"25% (3/12)",0.007365383,2.13,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","Cluster 21: response to stimulus"
"169","21",7.27,"GO:0071230","cellular response to amino acid stimulus","Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups.","5.263% (2/38)",0.7895211,0.1,NA,NA,"13.158% (5/38)",0.009861756,2.01,"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1","Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Cluster 21: response to stimulus"
"170","21",8.57,"GO:0071361","cellular response to ethanol","Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.","33.333% (4/12)",0.009533181,2.02,"Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___RNAseq.g4959.t1;Pocillopora_acuta_HIv2___TS.g18947.t1","Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Tumor protein p53-inducible nuclear protein 1 (Stress-induced protein) (Thymus-expressed acidic protein) (TEAP) (p53-dependent damage-inducible nuclear protein 1) (p53DINP1);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)","0% (0/12)",1,0,NA,NA,"Cluster 21: response to stimulus"
"171","21",7.84,"GO:0110096","cellular response to aldehyde","Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aldehyde stimulus.","0% (0/25)",1,0,NA,NA,"20% (5/25)",0.001511924,2.82,"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1","Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Cluster 21: response to stimulus"
"172","21",7.56,"GO:0071300","cellular response to retinoic acid","Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.","6.061% (2/33)",0.7198201,0.14,NA,NA,"24.242% (8/33)",1.325199e-05,4.88,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Cluster 21: response to stimulus"
"173","22",7.5,"GO:0002456","T cell mediated immunity","Any process involved in the carrying out of an immune response by a T cell.","5.714% (2/35)",0.7497751,0.13,NA,NA,"20% (7/35)",0.0001730983,3.76,"Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g13017.t1;Pocillopora_acuta_HIv2___TS.g7062.t1","Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Protein jagged-1 (Jagged1) (CD antigen CD339);Aryl hydrocarbon receptor (Ah receptor) (AhR);Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","Cluster 22: immune effector process"
"174","22",9.27,"GO:0001868","regulation of complement activation, lectin pathway","Any process that modulates the frequency, rate or extent of the lectin pathway of complement activation.","66.667% (4/6)",0.0004159939,3.38,"Pocillopora_acuta_HIv2___RNAseq.g12286.t1;Pocillopora_acuta_HIv2___RNAseq.g12290.t1;Pocillopora_acuta_HIv2___RNAseq.g12292.t1;Pocillopora_acuta_HIv2___TS.g3256.t1","Fucolectin-4;Fucolectin;Fucolectin;Fucolectin-3","0% (0/6)",1,0,NA,NA,"Cluster 22: immune effector process"
"175","22",7.42,"GO:0006956","complement activation","Any process involved in the activation of any of the steps of the complement cascade, which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes; the initial steps of complement activation involve one of three pathways, the classical pathway, the alternative pathway, and the lectin pathway, all of which lead to the terminal complement pathway.","20.69% (6/29)",0.5204977,0.28,NA,NA,"27.586% (8/29)",0.008990649,2.05,"Pocillopora_acuta_HIv2___RNAseq.21012_t;Pocillopora_acuta_HIv2___RNAseq.g30322.t1;Pocillopora_acuta_HIv2___RNAseq.g8820.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8922.t1;Pocillopora_acuta_HIv2___RNAseq.g9068.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___TS.g23144.t1","Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment];Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain];Complement factor B (EC 3.4.21.47) (C3/C5 convertase) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment];Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain]","Cluster 22: immune effector process"
"176","22",8.29,"GO:0006958","complement activation, classical pathway","Any process involved in the activation of any of the steps of the classical pathway of the complement cascade which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes.","6.25% (1/16)",0.7129348,0.15,NA,NA,"31.25% (5/16)",0.0001610504,3.79,"Pocillopora_acuta_HIv2___RNAseq.g8820.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8922.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___TS.g23144.t1","Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment];Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain];Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain]","Cluster 22: immune effector process"
"177","23",9.27,"GO:0070654","sensory epithelium regeneration","The regrowth of a sensory epithelium following its loss or destruction.","0% (0/6)",1,0,NA,NA,"50% (3/6)",0.000783016,3.11,"Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1","Protein Wnt-8b;Protein Wnt-8b;Protein Wnt-8b","Cluster 23: biological_process"
"178","23",5.32,"GO:0009611","response to wounding","Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.","10.593% (25/236)",0.04942621,1.31,NA,NA,"10.169% (24/236)",0.003353264,2.47,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g22559.t1;Pocillopora_acuta_HIv2___RNAseq.g26270.t1a;Pocillopora_acuta_HIv2___RNAseq.g27031.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g30215.t1;Pocillopora_acuta_HIv2___RNAseq.g4785.t1;Pocillopora_acuta_HIv2___RNAseq.g4791.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g5308.t2","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1);Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2);Protein Wnt-7a;Matrilin-4 (MAT-4);Matrilin-2;Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Coagulation factor VIII (Procoagulant component);Coagulation factor VIII (Procoagulant component);Protein jagged-1 (Jagged1) (CD antigen CD339);Matrilin-2;Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Cluster 23: biological_process"
"179","23",7.69,"GO:0090303","positive regulation of wound healing","Any process that increases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.","0% (0/28)",1,0,NA,NA,"21.429% (6/28)",0.000342573,3.47,"Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___TS.g5308.t2","SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Cluster 23: biological_process"
"180","23",9.27,"GO:0010185","regulation of cellular defense response","Any process that modulates the frequency, rate or extent of cellular defense response.","66.667% (4/6)",0.0004159939,3.38,"Pocillopora_acuta_HIv2___RNAseq.g12286.t1;Pocillopora_acuta_HIv2___RNAseq.g12290.t1;Pocillopora_acuta_HIv2___RNAseq.g12292.t1;Pocillopora_acuta_HIv2___TS.g3256.t1","Fucolectin-4;Fucolectin;Fucolectin;Fucolectin-3","0% (0/6)",1,0,NA,NA,"Cluster 23: biological_process"
"181","23",8.66,"GO:0006953","acute-phase response","An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.","0% (0/11)",1,0,NA,NA,"27.273% (3/11)",0.005669355,2.25,"Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g4785.t1;Pocillopora_acuta_HIv2___RNAseq.g4791.t1","Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Coagulation factor VIII (Procoagulant component);Coagulation factor VIII (Procoagulant component)","Cluster 23: biological_process"
"182","23",5.03,"GO:0009617","response to bacterium","Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium.","9.333% (28/300)",0.1334817,0.87,NA,NA,"7.667% (23/300)",0.0003359026,3.47,"Pocillopora_acuta_HIv2___RNAseq.10171_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g10378.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g19470.t1;Pocillopora_acuta_HIv2___RNAseq.g24413.t1;Pocillopora_acuta_HIv2___RNAseq.g26270.t1a;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g8087.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g8820.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g9068.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___RNAseq.g9381.t1;Pocillopora_acuta_HIv2___TS.g13017.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g5618.t1","Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin);Hemicentin-1 (Fibulin-6) (FIBL-6);Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206);Hemicentin-1 (Fibulin-6) (FIBL-6);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP);Toll-like receptor 2 (CD antigen CD282);Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Hemicentin-1 (Fibulin-6) (FIBL-6);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);NFX1-type zinc finger-containing protein 1;Hemicentin-1 (Fibulin-6) (FIBL-6);Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment];Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Complement factor B (EC 3.4.21.47) (C3/C5 convertase) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment];Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment];Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Aryl hydrocarbon receptor (Ah receptor) (AhR);Hemicentin-1 (Fibulin-6) (FIBL-6);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","Cluster 23: biological_process"
"183","23",9.27,"GO:0009608","response to symbiont","Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a symbiont, an organism living with an organism of a different species in close physical association. The symbiont is defined as the smaller of the organisms involved in a symbiotic interaction.","0% (0/6)",1,0,NA,NA,"50% (3/6)",0.000783016,3.11,"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___TS.g11002.t4","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Cluster 23: biological_process"
"184","23",7.02,"GO:0050982","detection of mechanical stimulus","The series of events by which a mechanical stimulus is received and converted into a molecular signal.","18.367% (9/49)",0.009675179,2.01,"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.g15159.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g702.t1;Pocillopora_acuta_HIv2___RNAseq.g710.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___TS.g15134.t1;Pocillopora_acuta_HIv2___TS.g21857.t1;Pocillopora_acuta_HIv2___TS.g4109.t3","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Sperm receptor for egg jelly (suREJ);Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Mechanosensory protein 2;Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3);Pejvakin (Autosomal recessive deafness type 59 protein)","2.041% (1/49)",0.825932,0.08,NA,NA,"Cluster 23: biological_process"
"185","23",8.35,"GO:0050922","negative regulation of chemotaxis","Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.","0% (0/15)",1,0,NA,NA,"26.667% (4/15)",0.001474884,2.83,"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g9049.t1","Roundabout homolog 2;Roundabout homolog 2;Roundabout homolog 1;Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1)","Cluster 23: biological_process"
